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Inclusion bodies (IBs) are insoluble protein aggregates that can be formed within 
recombinant bacteria. These aggregates, once thought to be an obstacle in recombinant protein 
expression and purification, have recently gained attention to their potential applications in 
biotechnology and medicine. However, despite their attractive qualities, there have been little 
investigations into their high-resolution structure. Presented is the method quenched hydrogen-
deuterium amide exchange (qHDX), a method in which solvent-exposed amide protons of IB 
aggregates are exchanged with deuterium, lyophilized, then dissolved in DMSO and observed by 
two-dimension nuclear magnetic resonance (NMR). This method allows one to probe the map the 
solvent-exposed and solvent-protected backbone amides of the aggregated protein.  
qHDX was optimized on IBs of Cu, Zn superoxide dismutase-1 (SOD1), a homodimeric 
metalloenzyme that is associated with the development of neurodegenerative diseases, including 
amyotrophic lateral sclerosis (ALS). The IB structure of SOD1 was probed using various mutants 
across three different expression conditions. Remarkably, the mutants all adopt similar, extensive 
native-like structure with some amyloid features, despite large differences in protein stabilities and 
mutation types. These results hold true across all measured expression conditions. These findings 
are of broad significance for understanding cellular protein aggregation. The structural 
characteristics of SOD1 IBs and effects of mutations may be valuable for advancing rational design 
of IBs. qHDX is a powerful tool that has potential to pave the way for advancements in the field 
of protein engineering as an effective method to measure the high-resolution structure of in vivo 
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1.1 Protein Folding, Misfolding, and Aggregation  
Proteins are large biomacromolecules that exist in all life on Earth. They are composed of 
amino acid monomers covalently linked through peptide bonds to form a linear sequence known 
as the protein’s primary structure.1 These linear sequences fold to form higher order structures.1 
There is debate on how or why exactly proteins fold the way they do.2,3 The classical model of 
protein folding (Figure 1.1A)2 postulates that a protein folds along a distinct pathway, forming 
clearly defined intermediate structures before it ultimately achieves the final native fold.2,4 This 
classical model provides a solution to Levinthal’s paradox. Levinthal proposed that there is no 
undirected folding process for proteins, as the time it would take a protein to randomly sample 
every potential form before finding its native structure is longer than the current age of the 
universe.2 Working at the same time as Levinthal, Anfinsen observed through his work on 
ribonuclease that protein folding was a quick process.5,6 Because of this, the idea was proposed 
that a protein folds via  intermediates, rather than randomly sampling available conformations.2 
This led to the development of Anfinsen’s dogma.5 
According to Anfinsen’s dogma, also known as the thermodynamic hypothesis, the primary 
amino acid sequence ultimately determines the native three-dimensional (3D) folded structure of 
the protein.2,5 Formation of the native structure requires three conditions to be fulfilled: a unique 
structure at a global free energy minimum, a stable structure that is unaffected by minor changes 
in the surrounding system, and a structure obtainable through a kinetic pathway.2,5 From this 
hypothesis, several new models of protein folding began to develop. These new theories led to the 
development of the energy landscape funnel theory (Figure 1.1B).2,7 This theory states that there 
are multiple routes that a protein may follow throughout the folding process.2,8 Consequently, there 
are many folding intermediates that the protein may sample before it reaches its native state. 
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However, rather than the random sampling of folding pathways, in most cases each folding 
intermediate will generally be more energetically favourable than the preceding one, to not escape 
Levinthal’s paradox.2 Both the classical model and energy landscape funnel are illustrated in 
Figure 1.1.2  
 
Figure 1.1: Classical and Energy Landscape Funnel Theories of Protein Folding. 
The classical model, A, displays clearly defined folding intermediates that are formed prior to 
reaching the final native structure. The energy landscape funnel, B, illustrates that proteins can 
sample conformations that are decreasing in energy, until an energy minimum is reached. Both 
models A and B are shown to follow the conditions established in Anfinsen’s dogma, while also 
not violating Levinthal’s paradox. Slightly modified from (A,B) Englander and Mayne, 20142 and 
(B) Hartl & Hayer-Hartl, 20093.  
Protein misfolding describes errors in the folding process.2 Such errors may occur when a 
protein is sampling conformations and forms an off-pathway folding intermediate.2,3 There are 
several aspects to a protein’s structure that can increase the probability of misfolding. These factors 
may include long range interactions in a native fold that may be difficult to form, and folding 
intermediates containing interactions that do not occur in the native state.3 Misfolded or partially 
folded proteins often contain solvent-exposed hydrophobic residues. This is in contrast to native 
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conformations, where these residues are generally buried in the core of the protein.3 This 
observation is consistent with the hydrophobic collapse model of protein folding, according to 
which a primary sequence collapses into itself due to the hydrophobic effect, and followed by 
further folding steps.9 Surface level hydrophobic interactions between two or more misfolded 
proteins can thermodynamically encourage the assembly of higher order structures, known as 
aggregates.3,8  
Protein aggregates can be formed through both covalent and non-covalent interactions.8 
Covalent linkages can include disulfide bonds through free cysteine residues, and non-covalent 
linkages can originate through van der Waals forces, dipole interactions, and hydrogen bonding.1,3 
The formation of these thermodynamically stable structures is often modeled to form through the 
assembly of two or more misfolded proteins, followed by formation of small, soluble aggregates, 
then further assembly into larger insoluble structures.3,8 Proteins involved in non-native 
interactions have been shown to be able to destabilize natively folded proteins and recruit them to 
the aggregate structure.3 This can be modelled into an energy landscape funnel, as illustrated in 
Figure 1.2.3  The stability of a protein directly correlates to the difference in free energy between 
folded and unfolded states at equilibrium.10 The thermodynamic stability of the protein describes 
the population of different states at equilibrium, and the kinetic stability is correlated to the rate of 
unfolding of the native state.8,10 The structure and stability of these aggregates can vary greatly, 
from highly ordered amyloid fibrils, to amorphous oligomers.3,8 These aggregates can form within 
neuronal cells of humans, where they are associated with the development of neurodegenerative 
diseases, including Alzheimer’s disease, Huntington’s disease, and amyotrophic lateral sclerosis 
(ALS).3,8,11 Due to the association of aggregate structures with these fatal diseases, it is imperative 
to have detailed structural characterization for these aggregates. There has been great recent 
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progress in defining the high resolution structure of aggregated proteins found in disease, notably 
amyloid fibrils, which are long unbranched aggregates that arrange in a cross-β sheet structure.12 
 
Figure 1.2: Energy Landscape of Protein Folding and Aggregation. 
The blue surface shows unfolded protein folding into its native state. The orange surface shows 
proteins assembling into higher order aggregate structures. These surfaces are overlapped, 
illustrating the ability of the native states of the protein to transition into aggregate structures 
following destabilization. Molecular chaperones within the cell act to prevent the conversion of 
natively folded proteins to higher ordered structures. Slightly modified from Hartl and Hayer-
Hartl, 2009.3 
The overexpression of proteins in bacteria frequently leads to their assembly into large, 
insoluble aggregates known as inclusion bodies (IBs)13,14. While IBs have historically often been 
considered an obstacle in the preparation of protein using E. coli expression systems15,16, recent 
investigations have turned to the useful functional characteristics of IBs15. IB applications have 
grown to include their use as functional nanomaterials15,17,18, industrial large-scale protein 
purification16,19, engineering of catalytically active protein aggregates20, and medically as potential 
vaccines21.  Central to developing such applications is a deeper understanding of the structures of 
proteins in IBs15. The current view is that IBs can contain a variety of conformations of 
6 
 
recombinant protein, including native structure, partially folded structures, and amyloid 
fibrils13,14,16 (Figure 1.3). Despite the promise of IBs, there have been very few systematic studies 
characterizing their structures at high resolution. Such structural characterization may provide 
information key for understanding the mechanisms governing IB structure and advance the design 
of more robust and advanced recombinant protein expression. 
In addition, IBs have been proposed as a useful model to study principles of aggregation 
in cells.14,19 This is supported by the concept of protein aggregation being a conserved cell 
response.19 While aggregation will differ greatly between human cells and E. coli, bacterial cells 
do provide a strong model to study the fundamentals of protein aggregation. There are noteworthy 
examples of IB research in disease from literature. A 2012 study by Invernizzi et al. investigated 
the aggregates of proteins with repeated glutamine (polyQ) motifs, which also occur in proteins 
that form aggregates in Huntington’s Disease.22 They found that the aggregates formed protected 
the cell from smaller soluble cytotoxic oligomers, displaying aggregation as a conservative cell 
response.19,22 Another study by Sabate et al. in 2009 reported that the rate of transmission by IBs 
containing prions is dependent on the local cellular environment during aggregation.23 Since IB 
formation and structure provide a tractable model to study aggregation-prone disease proteins, it 
naturally follows that the development of a robust method to study IB structure at high resolution 
would provide valuable information for aggregation associated neurodegenerative diseases. This 





Figure 1.3: Composition of IB Aggregate. 
Upon synthesis of recombinant protein in cells by the ribosome, the protein may aggregate into 
higher order structures. These large, dense aggregates may be composed of various forms of a 
recombinantly expressed protein, including native, unfolded, and partially folded structures as well 
as various assemblies thereof. Adapted from de Groot et al., 2009.14 
1.2 Neurodegenerative Disease 
1.2.1 Amyotrophic Lateral Sclerosis  
Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease, 
characterized by the death of motor neurons in the spinal cord, brainstem, and motor cortex.11,10  
Patients lose control of vital muscles, often resulting in death due to respiratory failure. Familial 
(fALS) is the inherited form of ALS and accounts for roughly 10% of all ALS cases, and sporadic 
(sALS), is the uninherited form which is responsible for about 90% of cases.11 There are many 
aggregation-prone proteins that have been linked to fALS, including Cu, Zn superoxide dismutase 
1 (SOD1).11 Approximately 15-20% of all fALS cases are found to be associated with SOD1 
mutations.10,11,25 Different fALS-associated SOD1 mutants result in different disease durations in 
ALS, however there is still considerable heterogeneity in duration even for a given mutation.26 
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Despite very extensive investigations, a clear relationship between biophysical properties of SOD1 
mutants and ALS disease characteristics has not been found.10,11 
1.2.2 Prion Strain Behaviour in Amyotrophic Lateral Sclerosis 
Prions are infectious misfolded proteins that promote the conversion of natively folded 
protein to a pathogenic state.27 Misfolded prion-like proteins form various non-native 
conformations and recruit other native proteins to enter these non-native conformations as well.27 
Different conformations, or strains, can aggregate to both smaller soluble oligomers and larger 
structures that can both potentially lead to neurotoxicity (Figure 1.4).27  There are emerging 
studies of prion-like spreading of misfolded and aggregated proteins in numerous 
neurodegenerative diseases.27–29 Different aggregate structures of ALS-associated proteins, 
including SOD1 and TAR DNA binding protein 43 (TDP43), have been observed in patients and 
may potentially contribute to varying degrees of neurodegeneration.28,30 
 
Figure 1.4: Model of Prion-Like Strains. 
Natively folded monomers convert to alternate misfolded conformations which can behave in a 
prion like way, self associating with native monomers to further aggregate into larger complexes. 
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The various misfolded species may contribute to neurotoxicity. Adapted from Vaquer-Alicea and 
Diamond, 201927.  
These remarkable findings support the hypothesis that differently mutated or covalently 
modified SOD1 proteins may form distinct prion-like assemblies with different toxic effects. This 
idea is supported by the yet-unexplained varying levels of neurodegeneration and disease 
characteristics amongst SOD1 mutants.26 For example, some mutants of SOD1 have average 
disease durations of less than one year, such as A4V, and others have average disease durations of 
over ten years, such as H46R.26 One potential origin of this variation in duration is prion-like 
propagation of these aggregates between neuronal cells, with different aggregate strains 
propagating in different ways.31 As noted above, there is no clear relationship between known 
quantifiable properties of SOD1 aggregates and disease duration.26  
 In recent years, evidence for the occurrence of prion-like protein aggregation in 
neurodegenerative diseases, including SOD1 in ALS, has been accumulating.30–33 A 2016 study 
by Ayers et al. examined mice that carry the G85R mutation of SOD1, which exhibit ALS 
symptoms that do not present until roughly 20 months of age. This G85R SOD1 was tagged with 
yellow fluorescent protein (YFP) to visualize SOD1 localization and assembly.31,32 These newborn 
mice were injected with spinal homogenates from paralyzed mice that carry the G93A mutation of 
SOD1, a mutant which causes symptoms to develop much earlier, at six months of age. This 
injection produced symptoms of neurodegenerative disease within roughly 3 months post-
injection.32 These transgenic mouse studies demonstrate that different mutant aggregates of SOD1 
result in different disease characteristics, and these characteristics can be replicated upon injecting 
ALS symptomless mice.30–32 The studies of SOD1 IB formation presented herein further examine 
the hypothesis of mutant dependent strain behaviour in aggregated SOD1. 
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1.3 Human Cu, Zn Superoxide Dismutase-1 
1.3.1 Structure and Function 
The structural features and function of native SOD1 provide context for understanding 
modes of misfolding and aggregation. SOD1 (Figure 1.5) is a homodimeric metalloenzyme that 
helps prevent build-up of the toxic oxygen species superoxide (O2
-) through its reduction to 
hydrogen peroxide and oxygen (Figure 1.6).11,10,34 The mature, or holo, form of SOD1 is a 
homodimer, and contains one intramolecular disulphide bond between residues Cys57 and 
Cys146, one zinc ion, and one copper ion per monomer.11,34 SOD1 also contains two long 
functional loops, the electrostatic loop, L7, and the zinc binding loop, L4. L7 helps guide O2
- to 
the active site, which contains a catalytic copper cofactor that is coordinated by residues His46, 
His48, His63, and His120.34 The other loop, L4, contains amino acids responsible for the 
coordination of a zinc structural cofactor, specifically His63, His71, His80, and Asp83.11,34 
 
Figure 1.5: Ribbon Structure of Human Cu, Zn Superoxide Dismutase 1. 
This SOD1 ribbon has its copper and zinc cofactors illustrated in orange and black, respectively. 
Loop L4, containing zinc binding residues His63, His71, His80, and Asp83, is shown in red, and 
loop L7, containing copper coordinating residues His46, His48, His63, and His120, is highlighted 
in blue. Sites of mutations of potential interest in this study are highlighted on the right monomer 




Figure 1.6: SOD1 Catalytic Cycle. 
SOD1 utilizes a ‘Ping-Pong’ type reaction to catalyze the reduction of superoxide into hydrogen 
peroxide and molecular oxygen to reduce oxidative stress in cells. At left, Cu(II) is reduced to 
Cu(I) by superoxide, and then at right oxidized to Cu(II) by a second equivalent of superoxide. In 
the first step, Cu(II) is reduced by a superoxide molecule, generating dioxygen (O2) and Cu(I). The 
Cu(I) is then re-oxidized by a second equivalent of superoxide, resulting in Cu(II) and hydrogen 
peroxide.35 The enzyme can then undergo repeated catalytic cycles. Figure provided by Dalia 
Naser. 
1.3.2 SOD1 Maturation 
SOD1 undergoes maturation to reach its mature holo form, and extensive studies show that 
immature forms of SOD1 have increased propensity to aggregate.10,11 The most immature form of 
this protein, reduced apo (E,E-SOD1SH) has no bound metals, has not yet formed its internal 
disulfide bond, and is predominantly monomeric.34 This protein matures through several 
maturation steps, as shown in Figure 1.7.36 A structurally stabilizing Zn ion is added through a 
currently unknown mechanism to form a singly metallated species (E,Zn-SOD1SH).34 Additional 
modifications include the introduction of a copper ion, which is responsible for redox reaction 
catalysis, by the copper chaperone protein for superoxide dismutase 1 (CCS).34,37 The internal 
disulfide bond between Cys57 and Cys146 is formed oxidatively, catalyzed by CCS during its 




Figure 1.7: Maturation Scheme of SOD1. 
E,E-SOD1SH, which is predominantly monomeric38, obtains a stabilizing zinc ion cofactor to form 
E,Zn-SOD1SH. This form then interacts with CCS to acquire a catalytic copper ion and to oxidize 
the disulfide bond between Cys57 and Cys146. This forms the mature protein, Cu,Zn-SOD1SS. 
Figure provided by Harmeen Deol.36 
 As SOD1 matures it becomes increasingly thermodynamically and kinetically stable.10 
Differential scanning calorimetry (DSC) experiments have been performed to quantify the global 
stability of SOD1 for different maturation states.10,36 Thermal stability is measured by increasing 
the temperature within the instrument and allowing the protein to unfold, with a higher melting 
point (Tm) indicating a more thermally stable structure.
36 DSC studies on SOD1 show an increase 
in Tm as the protein matures. Wild type E,E-SOD1
SH displays the lowest thermal stability, with a 
Tm of 47.6°C, while the most mature form of the protein, Cu,Zn-SOD1
SS, has a much higher Tm 
of 92.7°C.39,40 Recent DSC studies by Harmeen Deol of the Meiering group have shown the 
monomeric E,Zn-SOD1SH to have a Tm of about 57°C, indicating a more thermally stable structure 
than the metal-free variant, but less thermally stable than the mature form.36  
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Extensive studies have shown the immature E,E-SOD1SH is particularly prone to 
aggregation.10 Notably, under certain conditions, small amounts of aggregated E,E-SOD1SH can 
seed the aggregation of native-like stable structures of SOD1.10,41,42 This form of the protein has 
displays a tendency to aggregate, with different mutants forming aggregates of different sizes.10 
These findings suggest the possibility that partially mature forms of SOD1, notably zinc bound 
variants, might aggregate, given that they are not as thermodynamically stable as the mature 
form.37 This is supported by the observation that mature SOD1 can form aggregates upon loss of 
metals, which is promoted through mutation or impaired maturation.43 Investigating the extent of 
formation of these aggregates will prove valuable for studying both SOD1 maturation as well as 
the fundamentals of protein aggregation.  
1.4 Nuclear Magnetic Resonance 
1.4.1 NMR Background 
Nuclear magnetic resonance (NMR) is the primary method of analysis for this project. 
NMR spectroscopy is used to analyze the structures of a variety of biomolecules, notably 
proteins.44,45 NMR observes the nuclei of atoms with a non-zero nuclear spin, meaning that they 
must have an odd atomic mass number.44,45 The most commonly studied biologically relevant 
nuclei observed through NMR are hydrogen, carbon, and nitrogen.44,45 Carbon and nitrogen are 
both not naturally abundant in their 13C and 15N isotopes, respectively.44,45 Therefore, to facilitate 
high resolution NMR spectroscopy on a protein, it can be isotopically labelled with 13C or 15N 
during cell growth and protein expression.44,45 This will allow for the protein to have its 14N and 
12C atoms uniformly replaced with 15N and 13C atoms, respectively.44,45 
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The nuclei observed will resonate at a specific frequency within a magnetic field, and this 
frequency is dependent on the strength of the magnetic field as well as the local environment of 
the nucleus.44,45 By applying a uniform magnetic field to a molecule, multiple different signals will 
be observed based on the environment of the nucleus.44,45 These signals, called chemical shifts, 
can then be used to gain insight on the structure of a complex molecule, such as a protein.44,45 The 
common NMR experiment which will be used to analyze samples of our protein of interest, SOD1, 
is the 1H-15N heteronuclear single quantum correlation (HSQC) experiment. An HSQC is a two-
dimensional (2D) experiment that produces a 2D spectrum with a visible cross-peak for each 
detected proton-bound nitrogen atom.44,45 Consequently, a peak will be present for each amino 
acid amide backbone, except for that of proline, as well as –NH containing side chains in the 
protein.44,45  
1.4.2 Quenched Hydrogen-Deuterium Amide Exchange 
A powerful high-resolution technique that can be used for IB structural analysis is 
quenched hydrogen-deuterium amide exchange (qHDX). qHDX is an NMR approach that can be 
used to measure the high-resolution structure of insoluble aggregates that are a size unfit for 
traditional aqueous NMR experiments. A key early qHDX study by the Roder group in 199546 
helped pave the way for future studies in in-vitro protein aggregation. qHDX was developed for 
the purposes of peptide conformational studies.46 Zhang and coworkers dissolved the small peptide 
melittin in D2O and measured the extent of hydrogen-deuterium amide exchange in the aggregate 
through unfolding in DMSO and measurement using NMR.46 This resulted in the observation of 
both solvent-exposed and solvent-protected amino acid residues of the peptide.46 Interestingly, the 
same methodology has been further developed and applied to aggregates of purified protein.47,48 
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In these studies, amyloid fibrils formed by various purified proteins were subjected to qHDX, 
providing structural characterization at individual amino acid residue level.49,50  
The sequence of steps in a typical qHDX NMR experiment as applied to an aggregate 
structure is shown in Figure 1.8.49–51 There are many benefits to the use of quenched HDX, 
including the lower material costs on account of the high expression of IBs, the time saved and 
lack of loss of sample due to no purification, and it can provide accurate depictions of aggregates 
in the cell. Traditionally, structural characterization of large aggregates through solution NMR 
techniques or X-ray crystallography is met with significant difficulties due to the size limitations 
of each method, as protein aggregates are too large for observation using these tools.50 However, 
by unfolding the protein aggregate after it has undergone amide exchange, qHDX reveals structural 
data about the large protein aggregate while simultaneously reducing the structure to a size suitable 




Figure 1.8: Quenched hydrogen-deuterium amide exchange on protein aggregates. 
The solvent exposed amino acid amide protons are shown to exchange with deuterons when 
exposed to D2O, resulting in a loss of signal when observed through a 
1H-15N HSQC NMR 
experiment. When this exchanged sample is compared to a spectrum of unfolded protein that has 
not undergone qHDX, differences in signal intensities are observed. Signal intensities for amino 
acid residues that more closely resemble the fully protonated spectrum are considered to be more 
highly protected from the solvent, and residue signals that are considerably lower in intensity than 
the fully protonated spectrum are considered to be more solvent exposed.46,49,50  
qHDX has been applied previously as a method to characterize IB structures 51. Lei Wang 
et al. have used this method to display evidence that IBs, which were previously thought to be 
amorphous aggregates, contained organized cross-β amyloid structures 51. Additional 
investigations, including solid-state NMR spectroscopy (ssNMR), alongside low-resolution 
methods that include Fourier transform infrared (FTIR) spectroscopy, circular dichroism (CD), 
and X-ray diffraction have also suggested amyloid properties within IBs 17,52. Surprisingly, after 
these investigations, no further studies were reported after the initial intriguing results. These 
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results showed that different proteins exhibited very different protection in IBs ranging from just 
a short stretch of a loop, to most of the protein sequence 51.  
As we discovered, obtaining reproducible results requires careful control of many 
experimental aspects, described extensively in Chapter 2. In this thesis, qHDX is optimized to 
further probe the high-resolution structures of IBs, and applied to investigate the effects of 
mutations, protein expression conditions, and post-translational modifications on the structure of 
IBs.  
1.5 Research Objectives 
The focus of this thesis is on the optimization of qHDX NMR to determine the high-
resolution structure of IBs. SOD1 is used as the model system for optimizing the methodology. 
Through careful control experiments, the development of qHDX as a robust method that is quick, 
efficient, and cost-effective to measure, with accuracy, the structure of in-vivo aggregates was 
achieved. Consistency in results between both technical and biological replicates is key, as any 
observed differences must be a result of variability in IB structure. To achieve this reproducibility, 
careful control of experimental parameters is required, and the requisite controls are detailed in 
Chapter 2.   
Using the optimized method, the effects of point mutation, expression temperature, 
expression time, and post-translational modifications on IB formation and structure were 
investigated using SOD1. Three different expression conditions will be investigated in this 
research: reduced apo (rApo) SOD1 expressed at 37 °C for 4 hours, rApo SOD1 expressed at 25 
°C overnight (roughly 18 hours), and Zn-grown SOD1 expressed at 37 °C for 4 hours. The 
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2.1 Quenched HDX Workflow 
The workflow of hydrogen-deuterium amide exchange (qHDX) experiments on inclusion 
bodies (IBs) is summarized in Figure 2.1. The experiments consist of 3 stages: sample preparation 
(green) followed by NMR experiments (purple) and data analysis (orange). These stages are 
outlined here and described in detail in the following sections.  
 
Figure 2.1: Flowchart of the IB quenched HDX method. 
The workflow can be divided into three distinct stages: sample preparation (green), an 
experimental stage (purple), and data analysis (orange). The sample preparation requires very 
careful control of sample conditions, so as to avoid unintended variations in measured structures. 
With this control in mind, growth conditions can be varied and their effects on the structure of IBs 
can be observed by NMR. The experimental stage involves the acquisition of NMR spectra, with 
1H-15N HSQC spectra acquired for IB structural analysis, and 3D spectra acquired for sequence 
specific resonance assignment. The third stage, data analysis, involves the quantification of 
crosspeak signal intensities of 1H-15N HSQC spectra to provide high-resolution structural 
information of the aggregate.  
In the sample preparation stage, there are multiple experimental parameters that may be 
varied. Cell culture conditions can be varied to determine their effects on the structure of the IBs. 
Conditions of interest may include, for example, expressing different mutant forms of the protein 
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of interest, growth temperature, time of protein expression, and addition of protein cofactors such 
as metals. Throughout the procedure, there are key steps where other variables must be carefully 
controlled. For example, during the preparation of the IB sample from the insoluble fraction of the 
cells, it is important to control the sample homogeneity, IB concentration, and total protein 
concentration to avoid introducing unintended structural changes that interfere with NMR signal 
intensities. The IB preparation is initially resuspended in either H2O or D2O. Resuspension in H2O 
is used for two types of experiments: 1) a fully protonated control experiment and 2) a kint control 
experiment. The fully protonated control experiment is the acquisition of an NMR spectrum of the 
fully protonated unfolded protein where intensities are maximal. A kint control experiment 
measures the intrinsic rate of amide exchange in DMSO for each amino acid in the protein (see 
2.3.1). IBs are resuspended in D2O for qHDX experiments. Varying the time of resuspension in 
D2O allows different extents of exchange to occur. This measurable rate is known as the observed 
exchange rate in the aggregate (kex) 
50 (see 2.3.5). The exchange is stopped, or quenched, by flash 
freezing the sample in liquid nitrogen, lyophilized, then solubilized in DMSO buffer for NMR 
experiments. To minimize changes to the IB structure as well as signal scrambling, lyophilized 
samples are stored at -80 °C for a limited time (see 2.3.6).  
In the second stage, NMR experiments include acquiring 2D 1H-15N HSQC experiments 
for IB structural analysis (see 2.4.2), and 3D experiments to obtain sequence specific resonance 
assignments (see 2.4.1). The experiments described here are based on 10 minutes dead time from 
dissolving a qHDX sample and a 20 min 1H-15N HSQC spectrum acquisition time. The third stage 
of the workflow is the data analysis. Acquired NMR data is processed, and the cross peak signal 
intensities are quantified to measure both the extent of protection of the aggregate and the kint 
values of the sample (see 2.2.9, 2.3.1, 2.4.2). The entire workflow may be repeated to examine 
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new experimental conditions. We illustrate all the steps in the stages and representative results in 
the sections below.  
2.2 Materials and Methods 
2.2.1 Materials 
Solutions were prepared using Milli-Q ultrapure water and chemicals were analytical grade 
unless otherwise stated. TEN buffer, containing 20 mM tris(hydroxymethyl)aminomethane (Tris), 
1 mM ethylenediaminetetraacetic acid (EDTA), and 100 mM NaCl at pH 8.1, was stored at 4 °C. 
Bottles of D2O were sealed with Parafilm and stored at 4 °C. Using 10X M9 minimal media stocks, 
consisting of 500 mM Na2HPO4, 250 mM KH2PO4, and 5000 mg L
-1 NaCl, 1 L of 1X media was 
prepared and incubated overnight at 37 °C with shaking at 200 RPM. At the time of inoculation, 
0.4% Glucose, 100 μM CaCl2, 2 mM MgSO4, 500 mg L
-1 15N-NH4Cl (or 
14N-NH4Cl for non-
isotopically labelled samples), and 0.1% Thiamine-HCl, were added to the medium together with 
100 μg mL-1 ampicillin and 30 μg mL-1 chloramphenicol. Ultrapure 99.9% DMSO-d6 in single use 
1 mL glass ampules (Sigma-Aldrich) were used for NMR sample preparation. Stock solutions of 
1 M dithiothreitol (DTT) and 5% (v/v) dichloroacetic acid (DCA) were made in DMSO-d6 and 
stored at -80 °C. Note that the DTT was frozen in one-use aliquots, as it would otherwise alter the 
pH of the final solution.  
2.2.2 Cellular Growth and Protein Expression 
Our model protein, human Cu, Zn superoxide dismutase 1 (SOD1), was expressed in 
BL21(DE3) cells containing a pET 21 vector and grown overnight at 37 °C with shaking at 200 
RPM in 50 mL of Luria broth (LB) containing 100 μg mL-1 ampicillin and 30 μg mL-1 
chloramphenicol. 30 mL of the overnight culture was centrifuged at 4000g at 4 °C for 10 minutes, 
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and 20 mL of the supernatant was removed. The pellet was resuspended in the remaining 10 mL 
of the supernatant and used to inoculate 1 L of M9 minimal media containing the same antibiotics, 
then incubated at 37 °C with shaking at 200 RPM to an A600 of 0.6-0.8. Overexpression was 
induced using 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for expression at 37 °C, or 
0.5 mM IPTG for expression at 25 °C. Samples at 37 °C were grown for 4 h post-induction, and 
samples at 25 °C were grown for 24 h post-induction. The cells were pelleted by centrifugation at 
4000g at 4 °C for 20 min, flash frozen in liquid nitrogen, and stored at -80 °C. For NMR 
experiments, duplicate flasks (isotopically labelled and not labelled) are always grown together 
for each sample type (see 2.2.4).  
In addition to SOD1, we also used qHDX to analyze mutants of Adnectins, a family of 
engineered proteins derived from the human 10th fibronectin type 3 domain 53. All qHDX 
experimental work and data analysis on Adnectins were performed by Anna Schaefer in our group. 
Adnectin variants were expressed in E. coli BL21(DE3) pLysS cells containing a pET-9d vector 
24. Cells were grown as described for SOD1 with the following changes: selection was achieved 
using 50 μg mL-1 Kanamycin and 34 μg mL-1 chloramphenicol, expression was induced using 1 
mM IPTG and cells were grown at 37 °C following induction. 
2.2.3 Preparation of IB Samples 
Cell pellets were resuspended in 30 mL of TEN buffer, then flash-frozen in liquid nitrogen 
and rapidly thawed in a 37 °C water bath for 15 minutes, with gentle swirling every 5 minutes (a 
freeze-thaw cycle). 3 mg of DNase I (Grade II, Sigma-Aldrich) was then added to each sample 
and mixed by inversion. The sample was incubated for 45 minutes at 4 °C, then subjected to three 
more freeze-thaw cycles. The soluble and insoluble fractions were separated by centrifugation at 
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20,000g at 4 °C for 20 minutes and the supernatants were removed. The pellets were resuspended 
in 8 mL of TEN buffer to create a homogenous slurry and separated into eight 1 mL aliquots, each 
containing roughly 4 mg of insoluble SOD1 (confirmed by SDS-PAGE, typically performed for a 
parallel unlabelled growth). The samples were flash frozen and stored at -80 °C. 
2.2.4 Preparation of NMR Samples 
IB sample aliquots were thawed at room temperature, centrifuged at 21,000g at 4 °C for 20 
minutes and the supernatant was removed. The pellet was resuspended in 5 mL of either H2O for 
a protonated control experiment or an intrinsic exchange rate (kint) control experiment (see 2.3.1), 
or D2O for a qHDX experiment. The time of incubation in D2O for qHDX samples was varied to 
observe different extents of exchange. The sample was then flash frozen in liquid nitrogen and 
extensively lyophilized (48 hours). The lyophilized sample may be stored at -80 °C for a short 
period. We recommend no longer than two weeks, to avoid changes in aggregate structure and 
signal scrambling (see 2.3.6).  
To ensure the dead time prior to NMR data acquisition is minimized for a qHDX 
experiment (see 2.3.1), sample conditions were first determined for a replicate, non-isotopically 
labelled sample. This replicate will be referred to as the test sample. We find that separate aliquots 
of a given cell growth pellet provide consistent results in qHDX experiments, therefore one can 
determine optimal sample conditions on a single aliquot and use these conditions on replicates 
from the same cell growth. The sample to be analyzed for the experiment will be referred to as the 
qHDX sample. The test sample was dissolved in 500 µL of solution containing 470 µL DMSO-d6, 
30 µL of D2O, and 25 mM DTT (from 1 M DTT in DMSO-d6). The pD of the test sample (pD = 
pHread + 0.4; see 2.3.2) was then adjusted to 5.5 using 5% (v/v) DCA in DMSO-d6. A glass pH 
24 
 
probe with a ceramic reference junction was used for measurements to avoid unwanted reactions 
with DMSO. The same volume of 5% DCA required for the test sample was used to prepare the 
qHDX sample. The test sample volume was made up to 600 µL with DMSO-d6. This test sample 
was further used to set up NMR experimental conditions (see 2.2.6). A premixed 600 µL solution 
for the qHDX sample was prepared containing DMSO-d6, 30 µL of D2O, 25 mM DTT, and the 
volume of 5% (v/v) DCA determined using the test sample. This premixed solution was used to 
dissolve the lyophilized qHDX sample.  
2.2.5 NMR Experiments 
qHDX and kint control NMR experiments follow almost the same procedure as for the test 
sample. The key difference is that the kint control sample does not undergo amide exchange and is 
lyophilized directly out of H2O (see 2.3.1). A fully protonated control experiment was used as a 
reference for the amount of exchange in D2O samples; this control contains H2O and so did not 
undergo amide exchange; thus the protonated control spectra can be acquired without 
consideration of dead time. All NMR experiments were performed at a temperature of 19 °C (see 
2.3.4).  
2.2.6 Quenched HDX and kint Control NMR Experiments 
The NMR spectrometer setup was determined using the unlabelled test sample (2.2.4). 500 
µL of the test sample was slowly pipetted into an NMR tube (to avoid bubbles) and inserted into 
the spectrometer. For the test sample, the spectrometer reference signal was locked to DMSO-d6, 
the shims were adjusted, and spectral parameters were determined. A 1H 1D NMR experiment was 
performed, and the test sample was removed. The parameters determined were copied to 
experiment files for the qHDX sample.  
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The lyophilized qHDX sample was dissolved (~1 min of mixing by micropipette) in the 
premixed solution (2.2.4) and a timer was started. Next, the sample was centrifuged for 10 s, and 
500 µL of the supernatant was slowly pipetted into an NMR tube. The qHDX sample was inserted 
into the spectrometer, reference signal locked to DMSO-d6, the spectrometer was matched and 
tuned to the sample, and the shims readjusted. We have found this readjustment is generally fast, 
as the test sample is very similar to the qHDX sample. A 1H 1D NMR experiment was then 
acquired for the qHDX sample.  
Once the ten-minute mark on the timer was reached, a series of nine 20 min 1H-15N 
heteronuclear single quantum correlation (HSQC) experiments were initiated. After acquiring 
these spectra, the shim files were saved for acquiring the final three spectra after the sample 
reached H-D exchange equilibrium (see 2.3.1). The qHDX sample was removed from the 
spectrometer and stored at room temperature for one week, after which three additional 1H-15N 
HSQC spectra were acquired. The entire series of spectra was used to determine the kint of each 
amino acid residue in the sample (see 2.2.9 and 2.3.1), and the first 1H-15N HSQC spectrum was 
used to measure the relative IB protection (Figure 2.2) (see 2.2.9 and 2.4.2). 
2.2.7 Fully Protonated Control NMR Experiments 
Fully protonated control samples contain 5% (v/v) H2O and could be analyzed directly 
(without the use of a test sample). These control samples were prepared as described in 2.2.4, with 
H2O used in the place of D2O. A 
1H 1D NMR experiment followed by a 1H-15N HSQC experiment 
were performed. The 1H 1D NMR spectrum is acquired for normalization for sample concentration 
(3.2.2). This protonated 1H-15N HSQC spectrum is used alongside the qHDX 1H-15N HSQC 
spectrum to determine the relative protection of the aggregate (Figure 2.2) (see 2.2.9 and 2.4.2).  
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2.2.8 Sequence Specific Resonance Assignments 
To obtain NMR resonance assignments, protein was grown and expressed as described (see 
2.2.2), using 0.2% 13C glucose and 0.5 mg L-1 15N-NH-4Cl to make a double-labelled sample. Cell 
culture was grown at 37 °C for 6 hours post induction and prepared as in 2.2.3 and 2.2.4. Two 1 
mL aliquots of double-labelled SOD1 were combined to make an NMR sample. For making 
assignments, five spectra were acquired: HNCO, HN(CA)CO, HNCACB, CBCA(CO)NH, and 
HN(CA)NNH 54–59. The assignments for SOD1 unfolded in DMSO were determined by Dalia 
Naser in our group. Spectra were acquired based on standard Bruker parameter sets. 
 
Figure 2.2: Different 1H-15N HSQC spectra acquired for quenched HDX experiments. 
The signal intensities of each spectrum visibly decrease as the sample exchanges with D2O. Shown 
in dark blue is a fully protonated control experiment. All crosspeak intensities are at their 
maximum. Shown in light blue is a quenched HDX experiment. A ratio of the signal intensities 
measured in this spectrum and the fully protonated control experiment is taken, providing a 
measurement of the relative protection of the aggregate. Relative to the fully protonated control 
spectrum, there are peaks missing due to H-D exchange. Highlighted is an area within the pair of 
spectra that possess both highly protected residues and solvent exposed residues, illustrated by 
peaks with higher and lower signals in the quenched HDX spectra, respectively.  
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2.2.9 Data Analysis 
All 1H-15N HSQC spectra were processed using Bruker Topspin software with a 90 ° 
shifted sine bell squared window function. Processed spectra were analyzed using CCPNMR 
software 60, which allows for automatic picking of the cross peaks in a series of spectra, and fitting 
of these peak intensities as a function of time to a single exponential decay with an offset, to obtain 
the intrinsic rate constant for exchange, kint, for each amide. While kint can be determined for each 
qHDX sample signal decay for the 12 acquired 1H-15N HSQC spectra, it is important also to 
conduct an experiment in which fully protonated protein (rather than exchanged protein) is 
dissolved in DMSO with 5% D2O. This kint control experiment is valuable as the sample has higher 
starting signal and allows for more accurate measurement of kint values, while also permitting the 
identification of peaks with such high kint that they fully exchange within the dead time of acquiring 
the first 1H-15N HSQC (see 2.3.1).  
The first spectrum the decay series corresponds to an exchange time in 95% DMSO / 5% 
D2O of 20 min (10 min dead time plus 10 min corresponding to half of the time to acquire the 
1H-
15N HSQC spectrum) (see 2.3.1). Under suitable conditions, the ratio of the signal from the first 
spectrum to the signal of a fully protonated control spectrum can provide a quick measure of the 
extent of protection against exchange, and hence, residue-specific information on the aggregate 
structure. Further details on the quantitation of amide protection are given in 2.4.2.  
2.3 Control of IB Sample Conditions 
The sample conditions throughout qHDX experiments must be carefully controlled. 
Reasons for this strict control include ensuring that the signal observed by NMR is representative 
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of the IB structure, preventing unintended changes to the structure of the IBs, and ensuring the 
samples are as reproducible as possible, so that peak positions and kint do not change from sample 
to sample. The data acquired from a 1H-15N HSQC are typically mapped onto a protein structure 
to visualize protected or solvent-exposed amino acid residues 46,50. However, for the signal 
intensities observed at the time of the first NMR experiment to be representative of the sample at 
the time of dissolution, the intrinsic amide exchange rate of protein unfolded in DMSO (kint) must 
be sufficiently low (see 2.3.1).  
Throughout cell culture growth, protein expression, and sample preparation it is important 
that uncontrolled factors minimally impact the structure of the IB. Examples of such factors 
include the time and temperature of protein expression and sample preparation (see 2.3.4), and 
vigour of resuspending the IB sample in buffer after cell lysis. In addition, the chemical shifts of 
each amino acid residue must be consistent between spectra to allow for comparisons between 
samples. Because the protein is unfolded during protection readout, the chemical shifts of a given 
amino acid residue between replicates of a given mutant will be nearly identical, with the variations 
being dependent on sample conditions. These conditions include pH, water content, and 
temperature (see 2.3.2, 2.3.3, 2.3.4). Provided conditions are maintained between different 
samples, we find both chemical shifts and spectral intensities are directly comparable between 
mutants. The chemical shifts of residues are unchanged except near the site of mutation; here, clear 
sequence dependent changes in chemical shift allow for ready transfer of assignments between 
mutants (see 2.4.1).  
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2.3.1 Controlling the Intrinsic Exchange Rates 
Control of kint is critical for quantitative peak analysis and comparisons between qHDX 
experiments. As soon as the lyophilized sample is dissolved and unfolded in 95% DMSO / 5% 
D2O, the exposed amides start exchanging with deuterons according to their kint values. This 
forward exchange, while much slower than in aqueous conditions 46,50, can lead to significant 
signal loss in the dead time preceding NMR data acquisition. The addition of D2O is necessary, as 
without it the unfolded protein will undergo poorly controlled back exchange with H2O (see 2.3.3) 
49,50. To account for exchange, it is necessary to know the kint for the individual amino acid residues. 
Provided the value of kint is low enough, the observed NMR signals after the dead time will be 
close to the signals at the time of dissolution of the IB. Previous results from the Goto group 
recommended sufficiently low kint values as 9.0 x 10
-3 min-1 or lower 50. For kint of 9.0 x 10
-3 min-
1, the half-life for exchange is ~77 min; therefore, with a  deadtime of 10 min and 1H-15N HSQC 
acquisition time of 20 min, signal intensity at the midpoint of sample acquisition will decrease to 
~85% of the original intensity 50. The value of kint depends on multiple factors: the sample pH, the 
water content of the sample, the sample temperature, and the amino acid type; thus, it is crucial 
that these conditions be carefully controlled 46,49,50.  
Values of kint can be measured by acquiring a series of 
1H-15N HSQC spectra. Here, a 
sample suspended in H2O is lyophilized and then dissolved in 95% DMSO buffer with 5% D2O 
(Appendix Figure A2.1). The fully protonated amide groups then exchange with D2O, and the 
extent of exchange is monitored by measuring 1H-15N HSQC spectra as a function of time. Note 
that the difference in signal between the first 1H-15N HSQC and a fully protonated sample in 95% 
DMSO / 5% H2O corresponds to signal lost in the dead time, and residues that show very low or 
no signal in the first spectrum cannot be assessed by qHDX as they exchange too fast to measure. 
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Using five to ten half-lives of signal decay to define kint, we have found that 7 days is sufficient 
for our slowest residues to equilibrate (Figure A2.1). We recommend acquiring ~12 spectra 
throughout the exchange, including three at the time of equilibrium, to accurately determine kint 
values. The crosspeak intensities for each residue are measured and fit to a single exponential 
decay with an offset, where kint is the rate constant of the decay. Residues with a kint value smaller 
than the recommended value of 9.0 x 10-3 min-1 decay sufficiently slowly that their signal intensity 
is a reasonable measure without a correction of the signal at time of dissolution 50. For samples 
with limited signal to noise, and hence increased experimental uncertainties and apparent 
variations in measurements of kint for separate samples, using an average over multiple samples of 
kint values can decrease experimental variability in the results. Also, kint values can be used to 
calculate the signal at the time of dissolution (correcting for exchange in the dead time), as we did 
here for SOD1 using the averages of 18 values – two biological replicates of nine mutants (see 
2.2.9) using Eq. 1:  
Corrected signal intensity 
= A * e(-kint av*t) + C       ............................................................................................................. Eq. 1 
where A is the amplitude of the fit of the 12 spectra decay, kint av is the average kint value for a 
specific residue across 18 samples, t is zero for the back-calculation, and C is the offset value of 
the fit.  
Residues with larger values of kint decay too rapidly for quantitation without correction for 
forward exchange 50. The results described here do not include corrections for forward exchange 
in the dead time, which can be neglected in some conditions, including if the fraction of residual 
H2O in the sample (χH) is less than 0.3 (see 2.3.3) 
49,50 and if kint is less than 9.0 x 10
-3 min-1. If 
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these conditions cannot be met, then corrections for exchange can be made by measuring kint and 
correcting for signal loss in the experimental dead time, as described by Hoshino et al., 2007 50, or 
by taking a ratio of the reference spectrum to the exchanged spectrum 50. In situations where 
requisite conditions are satisfied, the measured 1H-15N HSQC signal intensities for each amino 
acid residue in the protein can be used directly to assess IB structure. 
kint values obtained for IBs SOD1 and Adnectins (measured by Anna Schaefer, included 
with permission) were compared with values obtained previously for in vitro fibrils of pure prion 
protein (PrP) under similar solution conditions of DMSO, pH, and temperature 61 (Figure 2.3). 
Overall, the kint values are similar between the three proteins and between different amino acids, 
within experimental variation. Some amino acids may have inherently faster or slower exchange, 
for example, Gly and Asp versus Val and other hydrophobic residues, respectively. The values for 
His standout as particularly high for SOD1, with average kint for His in SOD1 of 4.24 x 10
-2 min-
1, over four times higher than the recommended threshold value of 9.0 x 10-3 min-1 for kint. The 
high kint values for His residues preclude quantitative analysis of their protection in SOD1 IBs. 
The variation in kint tends to be higher for amino acids with higher exchange rates, which likely 
reflects higher uncertainties in the kint determination due to faster signal decay. Accordingly, using 
average values of kint can be beneficial to decrease experimental scatter in the protection analysis 





Figure 2.3: Measured intrinsic rate constants of amide exchange for different amino acids. 
Values are plotted for SOD1 (teal) and Adnectin (purple) IB samples together with literature values 
for pure PrP aggregates (light grey) 61. Values include results for 18 SOD1 samples (two biological 
replicates for each of nine different mutants), six Adnectin samples and a single mutant (P101L) 
for PrP 61. Data are shown as box plots, with horizontal line at the median values and ‘x’ at the 
mean values. Boxes correspond to the interquartile ranges. Individual data points are shown as 
circles. For residues with one data point the mean and median are coincident. For residues with 
two data points, edges of the box correspond to the two data points. 
2.3.2 Sample pH 
The pH of the sample influences both the values of kint (see 2.3.1) and the observed 
chemical shifts (Figure A2.2). As the sample in qHDX experiments contain D2O rather than H2O 
the acidity of the sample is measured as pD (pD = pHread + 0.4) 
46. Previous results from the Roder 
group showed that the kint of amide protons in 95% DMSO / 5% D2O is at a minimum at a pD of 
~5.5 46. The pKa of dichloroacetic acid (DCA) in 95% DMSO / 5% D2O is 5.72, which makes it 
suitable for buffering at the target pD of 5.5 in order to minimize kint 
46. Trifluoroacetic acid has 
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also been used previously for some similar experiments 51,62; however, its pKa in 95% DMSO is 
3.45 63 which does not result in appropriate buffering at the target pD of 5.5, therefore it is not used 
in the qHDX experiments reported here. Nevertheless, it can be considered if DCA does not 
sufficiently solubilize the sample 62. After three endpoint 1H-15N HSQC spectra are obtained at 
equilibrium (2.3.1), the pD of the sample can be accurately measured using a glass pH probe with 
a ceramic reference junction. It is necessary to use this specific type of pH probe, as DMSO will 
damage many other probes, such as those made of standard epoxy. The sample is still buffered 
after this week-long period and should provide an accurate pD reading. The pD is measured after 
the final spectra are acquired, as opposed to during the sample preparation stage, to prevent the 
addition of salt and water through the reference junction of the pH probe (see 2.3.3 on minimizing 
H2O content).  
The pD of the sample can also be assessed by using DCA as a convenient internal reporter. 
A 1H 1D NMR spectrum of DCA contains a strong lone singlet peak at approximately 6.5 ppm in 
95% DMSO at pD 5.5, corresponding to the acetyl group proton of DCA. A linear relationship is 
observed between the chemical shift of this peak and the measured pD of the sample (Figure 
2.4A). This can be used to assess the approximate pD of the sample before acquiring the 1H-15N 
HSQC series (Figure 2.4BC): if the difference in chemical shift between the DCA peak and the 
most upfield methyl peak is greater than ~5.6 ppm it can be concluded that pD of the sample is 
higher than pD 5.5 and will consequently result in a high kint. Additional benefits of using the DCA 
reporter peak are that there are no complications arising from the addition of water through the 
junction of a pH probe, and the dead time between sample dissolution and NMR data acquisition 
is kept at a minimum. By ensuring appropriate sample pD, the kint will be minimized, therefore the 
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observed signal through NMR will be representative of the sample at the time of dissolution in 
DMSO.  
 
Figure 2.4: DCA methyl 1H peak as an internal indicator of sample pH. 
A) 1H 1D NMR spectral overlay between qHDX samples at different pD values, zoomed in to 
encompass the peak corresponding to the DCA addition. Its adjusted chemical shift, being the 
difference in chemical shift between the DCA peak and the most upfield peak in the methyl region, 
is plotted against measured pD and a linear relationship is observed. B) An ideal overlay between 
the setup test sample (light grey) and the 15N labelled qHDX sample (dark grey). Overlap between 
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the two peaks indicate near identical pD values. C) A non-ideal overlay between the setup test 
sample (light grey) and the 15N labelled qHDX sample (dark grey). The lack of overlap indicates 
that the sample pD is different than that of the setup test sample. 
2.3.3 Sample H2O Fraction, χH 
The fraction of residual water (χH = [H2O] / {[H2O] + [D2O]}) in the sample must be 
controlled for two key reasons. The first is the dependence of protein chemical shifts on χH, and 
the second is the exchange of sample amide deuterons with water protons or deuterons (see 2.3.1). 
As illustrated in Figure 2.5, there are clear differences in chemical shift between two spectra of 
samples that differ only in their water fraction.  
 
Figure 2.5: 1H-15N HSQC spectral overlay of a quenched HDX sample in DMSO with 0% 
(v/v) water added (blue) and 5% water added (red). 
Differences in chemical shifts are observed, therefore water content must be consistent between 
samples for the purposes of resonance transfer.  
Back exchange will occur if χH is larger than the fraction protected. As back exchange 
occurs, signal intensities will increase in acquired 1H-15N HSQC spectra. This could result in the 
misinterpretation of a solvent-exposed amide with a solvent-protected amide. To achieve 
sufficiently low χH small volumes of IB aggregates are suspended in large volumes of D2O for 
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exchange. For example, the 1 mL aliquots of IB aggregates (2.2.4) once centrifuged yield a pellet 
volume of 300 µL. This is suspended in 5 mL of D2O, resulting in a maximum χH value of <0.06 
(χH = 0.300/{5.0 + 0.300}) 
49. Additionally, to prevent back exchange, 5% D2O (v/v) is included 
in the NMR sample to ensure dominant forward exchange. Previous studies have illustrated an χH 
value less than 0.30, combined with appropriate kint (see 2.3.1) and the addition of D2O, will result 
in negligible back and forward exchange, providing high quality data without the need for 
additional corrections 49,50.  
The χH can also be minimized through extensive lyophilization. We recommend using a 
constant time for lyophilization of all samples of ~48 hours; this extended period ensures that as 
much moisture is removed from the sample as possible and helps to prevent continued exchange 
of the IB with residual D2O upon removal of the sample from the lyophilizer. To further minimize 
contaminating H2O in the sample one may use separate 1 mL DMSO-d6 ampules for each sample. 
DMSO is highly hygroscopic and will absorb H2O from the atmosphere, therefore it is necessary 
to minimize its exposure to air 64. A final key step to ensure the minimization of χH is the utilization 
of a set-up sample to measure the amount of DCA that must be added to the sample (see 2.2.4). 
Experiments on non-isotopically labelled samples have shown that water added through the 
junction of a pH probe can readily ruin the sample. Use of a set-up sample removes the need to 
check the pD of the sample during sample preparation, which prevents χH from increasing 
dramatically. Combining the steps described above allows χH to be suitably low and reproducible 
to allow for comparisons between experiments.  
A rough measure of the residual H2O in the sample can be obtained by acquiring a 
1H 1D 
NMR spectrum on the qHDX sample. Residual water in the NMR sample will appear as a peak at 
a chemical shift of about ~3.68 ppm (Figure A2.3). We have found that in samples with low 
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residual water, the largest peak in the spectrum is the solvent peak (DMSO, 2.511 ppm), followed 
by the height of the methyl peak (0.80 ppm), which is representative of protein concentration. In 
exchanged samples where the height of the water peak is greater than those of the DMSO or methyl 
peaks, the water content is too high (evidence by peak shifts in a 1H-15N HSQC spectrum and 
inconsistent sample signal compared to replicates). 
2.3.4 Temperature 
Another factor that affects kint is the temperature of the sample 
46,50. Since kint decreases 
with temperature, a lower kint will decrease forward exchange and allow for more accurate 
quantitation of qHDX. Therefore, it is best to lower the temperature as much as possible, while 
still maintaining suitable NMR spectral quality in terms of signal to noise and peak resolution 46,50. 
As the temperature is lowered to the freezing point of the DMSO, the molecular tumbling is 
slowed, broadening lines and decreasing peak intensity and resolution, while also reducing the rate 
of amide exchange. We recommend a temperature for NMR data acquisition of ~19 °C, the melting 
point of DMSO. We find that the NMR samples do not freeze at 19 °C, while providing spectra 
with a reasonable signal to noise and resolution (Figure A2.4). An additional recommendation is 
to choose a running temperature approximately equal to the ambient temperature of the room 
containing the NMR spectrometer. This results in less time required for sample thermal 
equilibration, therefore reducing the dead time prior to acquisition. It additionally ensures that 
exchange during dissolution and during experimental set-up is occurring at a consistent rate. These 
combined factors contribute to the recommended NMR acquisition temperature of 19 °C.  
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2.3.5 Time of IB Exchange in D2O 
As the IB is suspended in D2O its backbone amide protons are exchanging with deuterons 
(Figure 1.8). This exchange occurs more rapidly with solvent exposed amides, and slower with 
solvent protected amides. Upon very short incubation, only the solvent exposed amides will have 
the time to exchange with deuterons, but the solvent protected amides will remain protonated. 
From a single D2O incubation timepoint, an extent of protection can be measured. This provides a 
measurement of the extent of H-D exchange of the aggregate during the D2O at one timepoint. The 
extent of protection is defined as the ratio between the signal intensities of a qHDX 1H-15N HSQC 
spectrum and a fully protonated spectrum (Figure 2.2).  
The time of incubation in D2O can be varied to observe exchange of solvent protected 
residues (Figure 2.1). By measuring the extent of exchange and fitting to a function of time, the 
observed rate of hydrogen-deuterium exchange of the aggregate (kex) can be determined. As this 
exchange occurs in an aqueous solution, as opposed to kint which is measured in DMSO, measured 
kex values are roughly 100-1000 faster than measured kint values 
46,50. The ratio between this 
observed exchange rate for each residue, kex, and the intrinsic exchange rate for each residue if 
freely exposed, kint, is called the protection factor 
50. The protection factor is defined as P = kint/kex 
50. The protection factor differs from the previously mentioned extent of protection, as it is a 
measurement across a series of timepoints of D2O incubations. Typical protection factor values 
observed can range from 101 to 104 or higher 48,50. Through varying the duration of the D2O 
incubation, protection factors can be determined for each amino acid residue, providing high 




2.3.6 Storage of Lyophilized Samples  
The structure of lyophilized IB samples can change markedly over time, depending on their 
storage conditions. We have observed that the spectra acquired from replicate samples analyzed 
immediately after lyophilization, stored at room temperature, and stored at -80 °C all differ from 
one another (Figure A2.5). Proteins, even when lyophilized and stored at -80 °C, have been shown 
to be susceptible to changes in structure 65. Another factor to consider is differences in spectra as 
a result of residual moisture within the sample, either H2O, D2O, or HOD (water with one proton 
and one deuteron), exchanging with the lyophilized IB. Over time, especially at room temperature 
but also at -80 °C, this results in both the scrambling as well as lowering of observed signal 66. 
This scrambling leads to spectra with differences in measured signal intensity, and therefore 
influences the measured qHDX data. Consequently, when performing structural analysis of these 
aggregates it is recommended to observe the samples through NMR as soon as possible, as opposed 
to storing them at either room temperature or -80 °C.  
2.4 Spectral Analysis 
The spectra obtained from qHDX experiments can be analyzed to determine the relative 
protection of each amino acid residue in the IB. Provided the value of kint is sufficiently low, a 
residue can be analyzed without correction (see 2.3.1) 50. The residues with kint values that are 
deemed to be too high are not included in analysis, as their signal intensities are no longer 
representative of the signal at the time of dissolution. Published work by the Goto group includes 
mathematical corrections that can accommodate for high kint values, however provided residues 
are below the 9.0 x 10-3 min-1 threshold as described in 2.3.1, specific structural information can 
still be obtained.  
40 
 
qHDX experiments require optimization of spectral processing. Firstly, as the IBs are not 
purified from a cellular lysate, other proteins and cellular components will also be visible. 
Secondly, as the protein is unfolded, there is a high degree of overlap in the peaks, which can make 
some undistinguishable. Thus, the correct balance of signal-to-noise (S/N) and resolution must be 
found when processing the spectra. qHDX samples are also continuously exchanging their NMR-
observable amide protons for unobservable deuterons, therefore the signal diminishes over time. 
Spectral processing must be performed in a way to consider both signal to noise as well as signal 
resolution (see 2.2.9).  
2.4.1 Resonance Assignments on an Unfolded Protein in DMSO 
Sequence specific resonance assignments for unfolded SOD1 were obtained using a 
combination of standard 3D experiments for uniformly 15N, 13C -labelled protein (Figure A2.6). 
Along with having only one cross peak per amide, the HNCO spectrum also had the best S/N of 
the set, and consequently was the most convenient for finding the locations of amide peaks in the 
crowded regions of the 1H-15N HSQC. We found that Cα and Cβ chemical shifts were very similar 
for a given amino acid for the DMSO-unfolded proteins, and that sequence did not influence these 
shifts. Ala, Cys, Phe, Gly, Pro, Ser, Thr, Ile, and Val each have characteristic Cα/Cβ chemical 
shifts which can be used to easily identify amino acid type. Carbonyl shifts were less characteristic 
for amino acid type but were frequently essential for distinguishing assignments for sequence 
repeats, where Cα/Cβ shifts are identical. These trends do agree with the general behaviour of 
random coil peptides 67. Table 2.1 shows the average random coil chemical shifts for SOD1 




Table 2.1: Random coil chemical shifts of SOD1 in DMSO. 
Data shown are for uniformly 15N, 13C labelled A4V SOD1 in 95% DMSO / 5% H2O, pH 5.50. 
All spectra were acquired at 25 °C. All chemical shifts are displayed in parts per million (ppm). 
Different amino acids are shown to have characteristic Cα, Cβ, and N chemical shifts, allowing 
for assignment of the unfolded protein in DMSO.  
A very valuable spectrum for making assignments was the HN(CA)NNH 59, which 
provides connectivities of amide i to the 15N chemical shifts for the i + 1 and i -1 amides (no 
directionality). In unfolded polypeptides, amino acid types tend to cluster by type in the HSQC, 
with several (Ala, Gly, Ser/Thr) occurring in distinct regions of the 1H, 15N HSQC and resulting 
in, albeit limited, dispersion in the nitrogen dimension (Figure A2.6). This makes the 
HN(CA)NNH a powerful tool in resonance assignment, frequently leading to a specific sequential 
amide. 
Protein primary sequence is a major determinant on the feasibility of resonance 
assignments of the unfolded protein, and the utility of the listed set of spectra. In addition to unique 
Cα/Cβ or NH chemical shifts for specific amino acids, there are distinct primary sequence effects 
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on amide nitrogen. Residues preceded by Ala resonated upfield in nitrogen relative to others of the 
same amino acid type, whereas residues preceded by Ile or Val shifted downfield. This trend was 
checked for other proteins in DMSO and found to hold (Table 2.2). Thus, proteins rich in these 
residues, particularly if they occur in the sequence before more “difficult” (i.e. overlapped) amino 
acid types (Asn, Gln, Glu, Asp, Lys), can be much easier to assign and have the added benefit of 
having more dispersion/isolated peaks, making final analysis easier as well. Note that due to the 
larger chemical shift effects of Ala, Val, and Ile, which can sometimes extend through multiple 
adjacent residues, peak assignment transferring of neighbor residues should be done with extreme 





Table 2.2: Primary sequence effects on 15N chemical shifts of amino acids. 
Clear primary sequence effects are observed on the chemical shift of amide cross peaks.  Displayed 
are the effects on chemical shifts of residues preceded by A, I, and V. All chemical shift deviations 
are measured in DMSO, and we have measured sequence effects on our proteins, Adnectin and 



















 G501 -0.07 1.55 Q523 -2.24 1.32 M506   
 A521 1.39 1.115 L569 -1.34 1.46 L509 -1.68 1.46 
 I522 1.83 1.75 G575 -3.12 1.55 A520 -1.48 1.12 
 G526 2.24 1.55 L578 -3.25 1.46 F540 -0.79 1.75 
 L550 1.27 1.46 G584 -2.77 1.55 S580 -1.41 1.45 
 K563 0.94 0.52 T629 -2.47 1.35 R588 -2.17 1.12 
 N567 1.11 1.37 F564 -1.78 1.75 S600 -1.73 1.45 
 L586 1.64 1.46    V606 -1.80 1.35 
 E615 0.44 0.65    S607 -1.85 1.45 
 T621 1.88 1.35    N609 -2.42 1.37 
 N637 2.56 1.38    A614 -1.78 1.12 
 D648 0.82 0.68    V625 -3.45 1.35 
 L651 2.79 1.46    H626 -1.61 2.27 
       I628 -3.63 1.75 
       L632 -0.61 1.46 
Cyt C A51 2.00 1.20 F10 -1.25 2.05 E4 -1.63 1.94 
 N52 1.47 1.37 I58 -2.67 1.33 E21 -1.21 1.94 
 D93 1.31 1.18 F82 -1.12 2.05 G84 -2.08 1.31 
 Y97   K86 -3.17 1.40    
 T102 1.80 0.98 A96 -1.06 1.20    
GroES G23 2.07 1.48 V12 -2.60 2.41 I11 -2.82 2.45 
 A33 2.18 1.37 V26 -2.46 2.41 L27 -0.27 0.37 
 K34 1.44 2.04 V65 -1.82 2.41 L41 0.27 0.37 
 V43 3.41 2.41 D79 -0.65 1.63 G44 -1.83 1.48 
 I94 1.51 2.45 V95 -0.19 2.41 G62 -1.82 1.48 
       D84 -2.45 1.63 
Adnectin A15 2.12 1.33 T37 -1.60 1.35 S4 -0.90 1.79 
 T16 -0.73 1.35 S62 -0.64 1.79 V13 -1.86 1.69 
 R27 0.74 0.92 T73 -2.77 1.35 A14 -1.36 1.33 
 R32 0.85 0.92 S87 -1.03 1.79 Q48 -0.86 1.21 
 T60 2.12 1.35 N89 -1.43 2.02 D69 -0.33 1.66 
 V77 1.73 1.69 D95 -1.63 1.66 T78 -0.30 1.35 
SOD1 T2 -1.21 1.22 I18 -1.35 1.48 V5 -2.73 1.39 
 G56 1.92 1.50 N19 -1.65 1.37 C6 -3.06 2.22 
 G61 2.25 1.50 K36 -2.13 1.39 L8 -2.67 1.60 
 D90 0.69 0.50 E100 -1.34 0.93 Q15 -1.78 2.52 
 D96 -0.20 0.50 S105 -2.46 1.47 H48 -2.68 1.80 
 D124 0.81 0.50 I113 -1.87 1.48 G82 -2.73 1.50 
 G141 1.95 1.50 G114 -3.02 1.50 T88 -1.43 1.22 
 C146 2.13 2.22 G150 -2.83 1.50 A95 -0.92 1.00 
 Q153 2.01 2.52 A152 -1.69 1.00 S98 -2.45 1.47 
 I104 0.05 1.48    H120 -2.34 1.80 
       I149 -0.80 1.48 
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SOD1, as well as Cyt C (BMRB: 26973) 68, Fas1-4 (BMRB: 25425) 69, and GroES (BMRB: 18949) 
70. Depending on the preceding amino acid, the 15N chemical shift may move upfield or downfield 
relative to the average value for each amino acid type. The average value was determined per 
nucleus for each amino acid type.  
A general difficulty in assigning unfolded protein is sequence repeats. While pairs of amino 
acids that repeat in the sequence can be discerned in the 3D spectra used herein, longer stretches 
of repeated sequences may well require additional multi-dimensional experiments to be resolved.  
In further comparisons among mutant proteins, we found that mutations in residue i 
affected the chemical shifts of residues i+1 and i+2, with a larger effect on the chemical shift of 
i+1. While no consistent trend was found for residues preceded by Gly, we did find that mutation 
of residue i to Gly resulted in a clear upfield shift of residue i+1, a trend that is useful for 
transferring assignments to mutants. We recommend that if residues succeeding the mutation are 
in a crowded area of the spectrum, residues in that region should not be used for quantitation unless 
the shifts can be clearly identified, as peaks may be overlapped in unexpected areas (Figure A2.6). 
A useful check is to compare the intensity of each peak in a protonated spectrum: we found that 
these are consistent, and outliers in a mutant spectrum may be indicative of shifts in overlapped 
peaks. In addition to the peak intensities, kint values may also be checked to confirm peak identity, 
as kint values tend to be consistent per residue between different samples.  
2.4.2 Quantitation of Amide Protection 
The signal intensities of peaks in the 1H-15N HSQC spectrum report on the structure of the 
IB sample at the time of dissolution in DMSO. A facile measure of the extent of protection against 
exchange, and so structure in the IB, is the ratio of the signal from this spectrum and the signal 
intensities of a fully protonated control spectrum. This ratio will be referred to as the relative 
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protection. Amino acid residues with low relative protection are solvent-exposed in the aggregate, 
and residues with high levels of relative protection are solvent-protected (Figure 2.2).  
Taking the concentration of the protein of interest in NMR samples into account must be 
done carefully due to variations in overall sample concentration in the IB. Accordingly, we report 
the fraction of amide protected in a qHDX sample relative to fully protonated H2O sample using 
the following procedure. The smoothed intensity for each residue in the first 1H-15N HSQC 
spectrum was scaled for protein concentration by dividing by the average amide signal in the 
sample. 
Intensity of Residue i amide in D2O sample  
= Smoothed IntensityResidue i / (AverageIntensityAll )residues       ................................................. Eq. 2 
Since the average amide D2O signal for a sample is a combination of protein concentration 
and the extent of signal lost to exchange, the extent of exchange must be accounted for or else the 
fraction protected may be erroneously high. Accordingly, the extent of exchange for the qHDX 
samples was calculated as the ratio of the intensity of the 1H 1D amide region (7.5-8.5 ppm) of the 
qHDX sample divided by the intensity of the corresponding H2O sample (from the same growth), 
where these 1H 1D spectra were scaled for protein concentration using the most upfield peak in 
the methyl region (~0.81 ppm); the average ratio, R, for all SOD1 samples was 0.5. Thus, fraction 
amide protected was calculated as: 
Fraction of Residue i amide protected  




2.4.3 Replicate Samples 
Protein aggregation is well established to be variable among both in vitro and in vivo 
replicate experiments 3,13, thus analyses of IB structure by qHDX require averaging the results 
from repeated experiments. The variability in replicate experiments is illustrated in Figure 2.6. 
Provided identical sample conditions are maintained, there is consistency in the observed scaled 
signal intensities between biological replicates of SOD1 mutants (Figure 2.6AB). We find this 
trend in both fully protonated and qHDX samples. We also find that the standard deviation of 
scaled, fully protonated, signal intensity between biological replicate samples is lower than that of 
all SOD1 mutants analyzed (Figure 2.6C). This means that there is less error between biological 
replicates compared to other samples. Accordingly, we advise generally to use the fully protonated 
signal intensities of the same mutant when calculating sample protection, rather than the averaged 




Figure 2.6: Comparisons of replicate qHDX sample results. 
A) Biological replicates of G85R SOD1 fully protonated samples. Signal has been scaled using 
Eq. 2. B) Biological replicates of G41D SOD1 qHDX samples. Signal has been scaled using Eq. 
2. C) Comparison of the averaged standard deviation of all biological replicates and the standard 
deviation of all samples. The standard deviation between each pair of samples in one mutant were 
measured, then averaged across all mutants. The standard deviation across all samples were also 
measured. Each value was then divided by the average scaled signal across each mutant and 
represented as a percentage. We found that the averaged standard deviation values are considerably 
lower across the entire sequence, indicating that biological replicates have lower deviations from 
each other than they do to other mutants.  
2.5 Conclusions 
We report here a detailed and optimized qHDX NMR method for the structural analysis of 
IBs, aggregates formed in recombinant bacteria that have many potential practical uses. High-
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resolution structural data on these aggregates provides valuable information for further developing 
practical applications of IBs. Quantitative qHDX experiments require very careful control of 
experimental conditions, including sample pH, water content, temperature, and kint. Detailed 
qHDX data on SOD1 are presented in Chapter 3. Ultimately, high resolution qHDX structural 
analysis of IBs promises to illuminate molecular determinants of IB formation and provide 
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• 3.4 SOD1 qHDX Discussion (in part) 
• 3.5 qHDX applied to other proteins  





3.1.1 SOD1 Inclusion Bodies Extent of Formation  
Inclusion bodies (IBs) are cellular aggregates that commonly form upon overexpression of 
proteins in heterologous hosts71–73; these aggregates are of broad fundamental and practical 
interest74,75 as they are important in protein preparation16,24, as functional materials76–78, and are 
medically relevant to toxic protein aggregation in disease78. While IBs have been characterized 
using various low-resolution methods, their insolubility and heterogeneity14,78 has left a dearth of 
high resolution structural data, limiting understanding of the molecular details of their aggregation 
mechanisms and structures in vitro and yet more in vivo.   
The obstacle of aggregate heterogeneity can be overcome using quenched amide hydrogen-
deuterium exchange (qHDX) monitored by nuclear magnetic resonance (NMR), which has 
provided structural information at the level of individual amino acid residues for many purified 
and some in cell globular proteins.47,48,51 For IBs, protection against exchange was observed for a 
small proportion of residues, clustered together in the protein primary sequence and near regions 
predicted to form amyloid steric zipper assemblies. To date, the effects of mutations in globular 
proteins on IB structure at high resolution have not been determined. 
Cu, Zn-Superoxide dismutase (SOD1, Figure 3.1A) serves as an ideal protein model to study 
structural impacts of mutations on globular proteins in IBs. SOD1 is an attractive system for 
elucidating molecular mechanisms contributing to IB formation as many mutants associated with 
familial amyotrophic lateral sclerosis (fALS) promote its aggregation in disease 
(http://alsod.iop.kcl.ac.uk/Als) and their in vivo and biophysical properties have been extensively 
characterized79,80. We analyze a diverse set of fALS mutant SOD1 IBs, from freshly and gently 
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lysed cells, in solution using qHDX and complementary Fourier transform infrared (FTIR) and 
Congo red (CR) spectroscopies.  
 
Figure 3.1: SOD1 Structure, Stability, and IB Formation. 
(A) Native homodimer, with left subunit highlighting major structural features: β-strands 1-8 are 
numbered (β1- β8) and loops that make intermolecular interactions are coloured and numbered; 
PDB entry 1HL5. Right subunit shows mutations examined herein: grey/purple analyzed for % 
SOD1 in IB, purple also analyzed by qHDX, FTIR, and CR. (B) % cellular SOD1 in IB correlates 
with reduced apo Tm (left) and ΔGd (right). Points correspond to separate samples for SOD1 
mutants at 4 and 6 hours after induction of expression at 25 °C and 30 °C (Table 3.1). 
First, IB formation was measured for 18 chemically diverse fALS point mutations (Table 3.1) 
that are distributed throughout the protein structure (Figure 3.1A, right) in E. coli cells grown in 
metal-free media at 25 °C, 30 °C and 37 °C (Figure 3.1A, Appendix Figure A3.1, Figure A3.2). 
Under these conditions, the IBs are formed by immature SOD1, i.e., with reduced cysteines and 
unmetallated (rApo) (Figure A3.1). Native rApo SOD1 is a marginally stable predominantly 
monomeric 8-stranded β-barrel with dynamic loops25,40,81. Similar to some proteins82,83 but not 
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others24,72 , for SOD1 there is a correlation between increased IB formation and decreased stability, 
measured by the apparent midpoint temperature of its thermal unfolding transition (Tm) (Figure 
3.1B left, Table 3.1)40.  The Tm values report on global stability but not on accompanying changes 
in local stability. For example, local perturbations decrease the Gibbs free energy of dimer 
dissociation (ΔGd) in mutant apo SOD1 with oxidized disulfide bond
84. Notably, increased 
formation of mutant monomers with disrupted interfaces is also correlated with IB formation 
(Figure 3.1B right).  
















WT 26 20 10.3 2.8 59.1 47.6 92.7 
A4V 90 91 6.4 2.3 50.7 36.3 86.7 




G37R 53 61 7.6 3.2 50.1 33.5 
 
G41D 67 57   
 
45.2   86 
G41S 65 75   
  
  84.4 
H43R 77 68 7.5 1.7 48.1 35.4 86.3 








G85R 77 79   
 
54.7 40.7 77.5 
D90A 35 24   
  
  77.5 
G93A 71 45 7.2 1.7 47.9   87.7 
G93D 77 39   
 
45.6   85.1 
E100G 63 37 8.0 1.6 51.2 33.2 86.2 




I113T 60 45 7.1 1.4 47.1   88.2 




V148G 67 44 5.9 2.2 49.3 34 86.9 
V148I 29 40 8.9 5.7 60.5 51 92.7 
Table 3.1: Summary of Aggregation Propensity and Biophysical Parameters of SOD1 
%IB values are an average of 3 biological replicates measured previously by members of our group using 
SDS-PAGE and densitometry. ΔGdimer and ΔGmonomer are from Broom et al., 201584. Fitted apparent midpoint 
of thermal unfolding transition (Tm ) for reduced apo Tm’s are fromVassal et al., 201140, oxidized apo Tm’s 
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(ox apo, metal free with disulphides oxidized) are from Vassal et al., 200685, and holo Tm’s are from 
Stathopulos et al., 200639.  
3.1.2 SOD1 Aggregation Prediction 
As their name suggests, aggregation predictors can be utilized to predict the aggregation 
prone regions of a protein sequence. In addition to aggregation, there are prediction algorithms 
that can be utilized to predict other aspects of a protein sequence as well, including both 
hydrophobicity and secondary structure, among others. Aggregation was predicted for wild-type 
and the 9 mutant SOD1s characterized by qHDX using TANGO (sequence-based)86, ZipperDB 
(sequence-based)87, and CamSol (sequence- and structure-based)88,89 predictors. The Kyte-
Doolittle hydropathy index was utilized to determine the hydrophobicity of each mutant across 
their linear sequence90. Secondary structure and hydrogen bond predictions were obtained using 
RaptorX91.  
In general, the aggregation predictions differed in various details; however, all predicted a 
notable decrease in aggregation propensity within the β8 strand of V148G relative to WT (Figure 
3.2B). Normalized prediction results for every other mutant relative to WT are shown in Figure 
A3.3. TANGO predicted a pronounced decrease in aggregation propensity for V148G, a moderate 
increase for A4V, a slight increase for V148I and no change for the other mutants (Table 3.2). 
ZipperDB predicted substantial decreases in aggregation propensity in the vicinity of G37R and 
G85R, moderate decreases for G93D and V148G, moderate increase for G41S, and slight increase 
for A4V, G93A, and V148I (Table 3.2). CamSol predicted a pronounced decrease in aggregation 
propensity for V148G, moderate decrease for G37R, G41S, G41D, G85R and G93D, slight 
decrease for V148I, pronounced increase for A4V, and moderate increase for G93A (Table 3.2). 
RaptorX uses an 8-point prediction to obtain the probability that any given residue is a part the 
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following structures: 4 turn helix, 3 turn helix, 5 turn helix, ꞵ-strand, ꞵ-bridge, hydrogen bonded 
turn, bend, or a loop. Only very small changes near sites of mutation were observed. Various 
residues that are protected in loops in IBs are predicted by RaptorX to form H bonded turns (Figure 
3.2C). Residues that are predicted and observed to form β-strands in native SOD1 tend to show 
higher average protection than loop residues (Figure 3.2), consistent with packing of native-like 
monomers giving rise to protection in loops.   
Mutant CamSol TANGO ZipperDB 
WT 0.45 0.63 0.61 
A4V 0.00 1.00 0.60 
G37R 0.81 0.64 0.81 
G41D 0.80 0.63 0.41 
G41S 0.42 0.63 0.00 
G85R 0.66 0.64 1.00 
G93A 0.30 0.63 0.80 
G93D 0.82 0.63 0.80 
V148G 1.00 0.00 0.85 
V148I 0.53 0.58 0.40 
Table 3.2: Normalized Aggregation Propensity Predictions. 
The average total predictor score for each mutant was normalized using the following equation: 
Score = (average – minimum) / (maximum – minimum), for each individual predictor for them all 
to be on a scale of 0-1. For the predictors CamSol and ZipperDB, a higher number means the 
mutant is less aggregation prone. For the predictor TANGO, a higher number means the mutant is 




Figure 3.2: Aggregation and Secondary Structure Prediction for SOD1. 
(A) Stacked, normalized aggregation predictor scores for WT SOD1 using CamSol, TANGO, 
ZipperDB, and CamSol Structured86–88. Scores for each predictor are normalized to a range of 0-
1, corresponding to lowest and highest predicted aggregation propensities, respectively (see 3.2.2). 
(B) Differences in normalized predicted aggregation score for V148G with values for wild-type 
subtracted. See 3.2.2 Eq. 5 on calculating ΔResidue Aggregation Score. Negative values indicate 
regions predicted to aggregate less in V148G than in WT and positive values are predicted to 
aggregate more. Thus, V148G is predicted to be markedly less prone to aggregate at the C-terminus 
compared to WT, consistent with the observed qHDX data. (C) Hydrogen bonded residues 
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predicted by RaptorX (blue line) overlaid with average observed qHDX protection (green bars).  
Some residues in regions predicted to form turns  that are not protected against exchange in native 
SOD1 and not predicted to aggregate are protected in IBs (E24-G27 in L2, N53-C57, H63, S68 in 
L4, G108-C111 in L6, L126, S134, G141 in L7). (D) ZipperDB aggregation propensity for wild-
type SOD1. Regions with a Rosetta energy lower than -23 kcal mol-1 are highlighted in orange/red 
and are predicted to assemble into steric zippers. 
3.2 Materials and Methods 
All experiments, data acquisition, and data analysis are as described in Chapter 2. Covered 
in this section are the different growth protocol used for expressing SOD1 in the presence of Zn, 
and the normalization of aggregation predictor data. 
3.2.1 Protein Expression, IB Preparation, and NMR Data Acquisition 
Using 10X M9 minimal media stocks 1 L of 1X media was prepared and incubated 
overnight at 37 °C with shaking at 200 RPM. At the time of inoculation, 0.4% Glucose, 100 μM 
CaCl2, 2 mM MgSO4, 500 mg L
-1 15N-NH4Cl (or 
14N-NH4Cl for non-isotopically labelled 
samples), and 0.1% Thiamine-HCl, were added to the medium of reduced apo (rApo) samples, 
together with 100 μg mL-1 ampicillin and 30 μg mL-1 chloramphenicol. For Zn-bound samples, the 
same 1X M9 medium was prepared as specified in Chapter 2. However, in addition to these 
reagents, 1 mM ZnSO4 was added at this time as well. All Zn-containing inoculated M9 flasks 
were grown at 37 °C with shaking at 200 rpm for 4 hours, and expression was induced using 0.1 
mM IPTG once an A600 of 0.6-0.8 was reached. All remaining steps, including expression, 
harvesting, sample preparation, NMR data acquisition, and NMR data analysis remain the same as 
stated in Chapter 2.   
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3.2.2 Aggregation Prediction 
 The servers TANGO (sequence-based)86, ZipperDB (sequence-based)87, and CamSol 
(sequence- and structure-based)92 were used to predict aggregation propensities for each mutant 
SOD1. The sequence-based servers require only a primary sequence input, while CamSol uses a 
PDB file (PDB: 2GBU Chain A) for 3D structure-based prediction. In order to directly compare 
aggregation propensities predicted with different methods (which have different ranges of values), 
the prediction scores for each predictor were normalized on a scale of 0 to 1 as follows: 
Normalized Aggregation Score for Residue i  
= (PredictionScoreResidue i - PredictionScoreLowest )i / (PredictionScoreHighest - PredictionScoreLowest)      Eq. 4 
where PredictionScoreResidue i is the score for residue i, PredictionScoreLowest is the lowest predicted 
score for the protein sequence, and PredictionScoreHighest is the highest predicted score for the 
protein sequence. 
For the change (Δ) in aggregation propensity for individual residues in mutant relative to 
wild type, the difference in the residue scores obtained from each predictor were normalized using 
the absolute value of the difference for the residue with the maximum change:  
ΔResidue Aggregation Score  
= (PredictionScoreMutant - PredictionScoreWildType )Residue i / | (PredictionScoreMutant - PredictionScoreWildType )Max |         Eq. 5 
Thus, the largest Δ values will be +1 or -1, with positive values indicating an increase in 
aggregation propensity and negative values indicating a decrease.  
Secondary structure predictions including hydrogen bonded turns were obtained using 
RaptorX Property with SOD1 primary sequence and default prediction parameters91,93. 
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3.3 SOD1 qHDX Results 
3.3.1 Reduced apo SOD1 IBs expressed at 37 °C for 4 hours 
Here we illustrate qHDX results for IB samples of the enzyme human Cu, Zn superoxide 
dismutase 1 (SOD1). Like many proteins, SOD1, a protein associated with the devastating 
neurodegenerative disease ALS, forms IBs when overexpressed in E. coli94. To define the IB 
structures, we performed qHDX experiments for nine fALS SOD1s (Figure 3.1A, right) 
containing point mutations that alter residue charge, hydrophobicity, secondary structure 
propensity, and increase or decrease aggregation propensity; the mutant Tms range from ~51 °C 
(for V148I) to ~33 °C (for G37R) (Table 3.1). The qHDX experiments require a high level of IB 
formation, thus we measured qHDX for high aggregating reduced apo (rApo), the most immature 
form of SOD1 with reduced cysteines and no bound metals, mutants at 37 °C. Using resonance 
assignments for resolved amides (Figure A2.6, Table A3.1), residue assignments were transferred 
to the acquired 1H-15N HSQC of the qHDX sample for intensity analysis. 
The observed exchange is biphasic, as also reported for other IBs, and indicating 
conformational heterogeneity (Figure A3.7, Figure A3.8). The measured qHDX data show 
extensive protection throughout the protein, with the general protection pattern very largely 
maintained across mutants (Figure 3.3A). Notably, extensive protection is observed throughout 
the β-strands of the protein, implying the β-barrel structure within SOD1 may remain in-tact within 
the aggregate. This extensive protection (Figure 3.3A) is in sharp contrast to the much more 
limited localized protection reported for IBs of other proteins.51,95 Remarkably, the mutants display 
similar protection including and extending beyond the extensive protection observed for soluble 
native SOD1 (Figure 3.3G), despite large differences in protein stabilities and mutation type. One 
59 
 
notable exception is V148G SOD1, which, while still displaying extensive protection throughout 
the primary protein sequence, has decreased protection in β8 and loop L4, and increased protection 
in L6 (Figure 3.3A,H). The ratios of protection between all mutants and the average protection 
for this condition was determined in order to highlight any potential mutant-dependent differences 
in protection (Figure A3.4). Only V148G was found to differ significantly from the average 




Figure 3.3: Structure of Mutant SOD1 IBs from qHDX Analysis. 
(A) Fraction amide protected for 9 SOD1 mutants. Each bar is an average of two biological 
replicates. Gaps indicate areas of no data. (B) WT holo SOD1 traditional amide HDX protection.96 
(C) Kyte-Doolittle hydropathy index of WT SOD1.90 (D) TANGO86 (green) and ZipperDB87 
(grey) predicted aggregation regions in WT SOD1. More negative values correspond to higher 
predicted aggregation propensity.  V148G was predicted to have the largest effect of the mutations 
studied, markedly decreasing aggregation propensity near the C-terminus (Figure 3.2B). (E) Gain 
of interaction regions observed for steric zipper peptides by Ivanova et al.97 (light grey, top) and 
filaments of native dimers by Elam et al.98 (dark grey, bottom). (F) Residues that engage in native 
dimerization (D1) and non-native dimerization (D2, D3)25; see also Figure 3.10. (G) Average 
qHDX protection of all mutants except V148G shown on the holo SOD1 dimer (PDB 1HL5). 
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Protection from 0.5 to 1.0 is colored as light to dark blue, respectively. Grey indicates no data. (H) 
Ratio of V148G protection relative to the average qHDX protection. Ratio is colored from 0.5 to 
1.5 in pink to teal, respectively (PDB 2GBU). 
3.3.2 Reduced apo SOD1 IBs expressed at 25 °C overnight 
We further investigated the effect of expression time and expression temperature on the 
structure of IBs formed by SOD1. As shown in Figure A3.2, the proportion of SOD1 that forms 
IBs is decreased in cells grown at 25 °C relative to cells grown at 37 °C. With these differences in 
expression, we wanted to determine if there are structural differences in the IB under the two 
different conditions. To define these IB structures, we performed qHDX experiments for four 
fALS associated SOD1 mutants: A4V, G85R, G93A, and V148G (Figure 3.1A, right). These 
mutants were selected due to their lower thermal stability and ability to form sufficient IBs at a 
lower expression temperature to allow for quantitative analysis (Table 3.1). This is of interest, as 
extent of IB formation is correlated to decreasing reduced apo Tm (Figure 3.1B, left). As in 3.3.1, 
crosspeak intensities using resolved amides were measured for SOD1 expressed at 25 °C 
overnight, roughly 18 hours post-induction. Attempts were made to express SOD1 for 6 hours at 




Figure 3.4: qHDX amide protection of mutant SOD1s expressed at 25 °C overnight. 
(A) Fraction amide protected for four SOD1 mutants, A4V, G85R, G93A, and V148G, expressed 
at 25 °C overnight. Each bar is an average of two biological replicates. Gaps indicate areas of no 
data. The sequence is split into two rows for readability. The secondary structure of the protein is 
displayed above each row. (B) Zoom of regions of interest from the previous graph, highlighting 
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with red circles higher L6 and β8 protection in G93A relative to the other mutants expressed at the 
same conditions. Residues 117-128 were removed for legibility (split marked with a black 
squiggle). (C) Ratio of G93A protection relative to the average qHDX protection. Ratio is colored 
from 0.5 to 1.5 in magenta to teal, respectively (PDB 1HL4).  
Similar to IBs of SOD1 expressed at 37 °C for 4 hours, the measured qHDX data show 
extensive protection throughout the protein sequence, with the general pattern maintained 
throughout the different mutants measured (Figure 3.4). The observed pattern of amide protection 
is also, surprisingly, comparable to what was measured for IBs expressed at 37 °C for 4 hours, and 
the average protection of all mutants generally does not differ significantly between the two 
conditions (Figure 3.5). The fraction amide protection of each mutant was directly compared for 
each mutant across each condition, and the general pattern was largely maintained within 
experimental uncertainty between each expression condition (Figure 3.8, Figure A3.9). The 
exceptions to this trend are the mutants G93A and V148G. G93A shows increased protection in 
L6 and β8, and less protection in L4 relative to the average of the mutants expressed at 25 °C for 
4 hours (Figure 3.4B,C). Interestingly, V148G, which had a noticeably different amide protection 
pattern compared to the average protection of all other mutants at 37°C, did not display differences 
larger than experimental uncertainties relative to the average of the other mutants when expressed 
at 25 °C. The amide protection ratios between each mutant and the average protection for this 
condition was determined to highlight any potential mutant-dependent differences in protection 
(Figure A3.5). Only G93A was found to differ from the average protection of this expression 
condition. As highlighted above, the average fraction amide protected between the two conditions 
are comparable within experimental uncertainty (Figure 3.5), therefore the mutants G93A and 
V148G both show differences in their extent of amide protection depending on the expression time 
and temperature. These temperature dependent differences are further explored in section 3.4 and 




Figure 3.5: Comparison of average fraction amide protection between expression 
temperatures. 
Comparison of normalized protection between two different expression conditions. The 37 °C 
dataset is the average of 2 biological replicates across eight different mutant SOD1s: A4V, G37R, 
G41D, G41S, G85R, G93A, G93D, and V148I (Figure 3.3). The 25 °C dataset is the average value 
of two biological replicates for each of A4V, G85R, and V148G SOD1. G93A is not included in 
this average due to differences in amide protection outside of experimental uncertainties. Fraction 
amide protection is calculated as per Chapter 2 (see 2.4.2 for quantitation of amide protection). 
Error bars represent one standard deviation of the averaged data. The overall protection profiles 
between the 37 °C data and the 25 °C data are similar, indicating similar ensembles of SOD1 
conformations in the IBs. 
3.3.3 Zn-bound SOD1 IBs expressed at 37 °C for 4 hours 
In addition to measuring the aggregate structure of SOD1 expressed at a lower temperature, 
we investigated the effect of the presence of Zn during the expression of SOD1 IBs. Zn addition 
during the expression of SOD1 has been shown to stabilize the soluble native state; it was 
necessary to express SOD1 IBs at a higher temperature (37 °C) to ensure sufficient aggregation 
for qHDX analysis. Despite the increased expression temperature, not all mutants could be 
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analyzed by qHDX. Previous aggregation propensity studies performed in our lab have shown 
some mutant SOD1s remain largely soluble after 4 hours of expression, despite the increased 
expression temperature. 
 
Figure 3.6: qHDX amide protection of mutant SOD1s expressed at 37 °C for 4 hours with 
Zn. 
Fraction amide protected for 3 SOD1 mutants, A4V, G85R, and G93A, each expressed for 4 hours 
at 37 °C with Zn. Each bar is an average of two biological replicates. Error bars represent one 
standard deviation. Gaps indicate areas of no data. Normalized data determined from scaled signal 
of the first 1H-15N HSQC of the acquired series (see Chapter 2, 2.2.6).  
As seen with the rApo SOD1 IBs expressed at 37 °C for 4 hours and the rApo SOD1 IBs 
expressed at 25 °C overnight, SOD1 IBs grown in the presence of Zn show extensive protection 
throughout the protein sequence, with the general pattern in the protection profile maintained 
throughout all the mutants measured (Figure 3.6). Unlike the other two conditions, none of the 
mutants studied stand out as an outlier from the average fraction amide protection pattern of SOD1 
expressed at 37 °C for 4 hours with Zn outside of experimental uncertainty (Figure 3.6). Following 
the same trend as the 25 °C dataset, each mutant was compared to the average amide protection 
measured for rApo SOD1 expressed at the same conditions except without addition of Zn, and no 
considerable difference in protection was observed outside of experimental uncertainty (Figure 
3.7A). This trend also holds true when the same mutant is compared with itself at different 
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expression conditions (Figure A3.9), except for the previously mentioned exceptions – rApo 
V148G expressed at 37 C for 4 hours and rApo G93A expressed at 25 C overnight (Figure 3.8). 
This information is also plotted onto a ribbon structure to further highlight the aggregation prone 
regions of the protein, L4, L6, and β8 being the most protected (Figure 3.7B). As noted above, no 
differences in amide protection outside of experimental uncertainty estimates are observed 
between the metalated and rApo conditions. The amide protection ratios between each mutant and 
the average protection for this condition was determined to highlight any potential mutant-
dependent differences in protection, however no significant differences in amide protection were 




Figure 3.7: Average qHDX protection of mutant SOD1 expressed with and without Zn.  
 (A) Average qHDX protection for two biological replicates of the mutant SOD1s expressed at 37 
°C for 4 hours with Zn: A4V, G85R, and G93A, compared to the average qHDX protection for 
two biological replicates of mutant SOD1s expressed at 37 °C for 4 hours without Zn: A4V, G37R, 
G41D, G41S, G85R, G93A, G93D, and V148I (Figure 3.3). The sequence has been divided across 
two rows for readability. Error bars represent one standard deviation. Normalized data determined 
from scaled signal of the first 1H-15N HSQC of the acquired series (see Chapter 2, 2.2.6). (B) Left 
Average qHDX protection of all mutants (37 °C, 4 hours, with Zn) shown on SOD1 monomer 
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(PDB 2GBU). Right Average qHDX protection of all mutants (37 °C, 4 hours, rApo), expect 
V148G, shown on SOD1 monomer (PDB 2GBU). Protection from 0.5 to 1.0 is colored as light to 
dark blue, respectively. Grey indicates no data. 
3.4 SOD1 qHDX Discussion 
To elucidate the molecular basis for the observed extensive protection across each sample, we 
examined experimental and predicted biophysical properties of SOD1 (Figure 3.3B,C). The 
primary sequence distribution of protected amides in IBs generally resembles that in native rApo 
and holo SOD1, noting that generally protection is conferred primarily by intramolecular hydrogen 
bonding for globular proteins96. For each expression condition analyzed, all mutant SOD1s 
exhibited extensive protection throughout the 8 strands of the β-barrel (β1-β8) (Figure 3.3, Figure 
3.4, Figure 3.6). Protection in the loops connecting the strands is much more pronounced for rApo 
in IBs than expected for the soluble monomer25,99. The loop protection in the IBs resembles that in 
dimeric holo SOD1, which includes some intermolecular hydrogen bonding. Notably, the long 
loops, 4 and 7, are more extensively protected in the IBs than in the native dimer despite their 
strongly hydrophilic character90 (Figure 3.3C).  
To further discern the cause of the extensive protection in the IBs, regions in SOD1 with 
propensity to promote intermolecular interactions and aggregation were analyzed using predictors 
of structure and aggregation propensity, including TANGO86 and ZipperDB87 (Figure 3.2, Figure 
3.3D). The C-terminal strand, β8, is generally predicted as the most highly prone to aggregate, 
followed by β1. These strands as well as β2, β3 and L6 contain short stretches of residues with 
high predicted propensity to form steric zippers, assemblies consisting of hydrogen bonded 
antiparallel or parallel β-strands97. Previous experimental studies observed zipper formation by 
short peptides corresponding to β2, β3, β8, and L6, whereas a β2-β3 peptide formed a non-amyloid 
corkscrew oligomer97,100. It is important to note that native structure can modulate or prevent these 
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short sequences from being available to assemble into zippers101; also, the steric zipper regions in 
SOD1 comprise only a fraction of the many protected residues in the IBs.   
We therefore must consider additional contributions of native-like structure in IBs. A model 
based on the β2-β3 peptide oligomer proposed that much of the rest of the SOD1 sequence could 
adopt native-like structure. Moreover, multiple experimental studies show full-length SOD1 can 
form various native-like assemblies. “Amyloid-like” filaments of near-native apo SOD1 dimers in 
crystal structures involve inter-subunit packing and hydrogen bonding between L7 and β5-β6 
98,102,103, regions that also show HDX protection in IBs (Figure 3.3E). Furthermore, NMR 
experiments suggest rApo monomers of wild-type and fALS mutant SOD1s can form native dimer 
(D1) and 2 non-native dimers (a symmetric one, D2, and an asymmetric one, D3) in solution25,104 
(Figure 3.3F).  Importantly, the interfaces for these dimers include intermolecular interactions of 
loops L4, L6 and L7, which are also protected against exchange in IBs (Figure 3.3, Figure 3.4, 
Figure 3.6). Although the extent of IB formation is decreased at lower expression temperatures 
and with the addition of Zn, in all cases similar protection is observed throughout the mutant 
proteins (Figure 3.4, Figure 3.6). These findings are consistent with native-like conformations in 
SOD1 contributing to the IB structure. Due to the extensive similarities in amide protection 
observed across the 3 different conditions, the data suggest contributions of native-like structures 
in the IBs, and varying expression conditions affects the extent of aggregation rather than the 
structure itself.  
The altered HDX protection in V148G SOD1 (Figure 3.3H) further supports contributions of 
D1, D2 and D3 to IB structure. V148G is situated in β8, packing in the center of the native D1 
dimer interface (Figure 3.1A), which is much weakened by the V148G mutation84. Increased 
dissociation of native D1 would decrease protection in β8 and L4, and the non-native asymmetric 
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D3 interface is also likely to be disrupted by V148G25 thereby decreasing protection of L7. Thus, 
the relative protection of L6 due to a higher relative population of symmetric D2 may be increased, 
as observed in V148G. Interestingly, this altered protection is only observed at 37 °C, and not at 
25 °C (Figure 3.8). V148G has one of the lowest thermal stabilities of all mutant SOD1 analyzed 
in this study and at 37 °C, it is more unfolded than at 25 °C. As the protein becomes more dynamic, 
it is believed more energetic pathways for assembly may become available105. This could result in 
changes for key structural regions involved in processes such as in the native D1 dimer interface. 
Multiple pathways are likely accessible to SOD1 mutants but to varying extents. For instance, if 
the packing of residue 148 is affected by this mutation, it could make other pathways more 
accessible, like the formation of non-native dimer interfaces D2 and D3. At 25 °C, where the 
protein itself is more folded and less structurally dynamic, there may be less pathways accessible. 
For instance, the loops involved in the native interface may be less flexible and therefore more 
likely to encourage the formation of the native D1 dimer interface relative to the non-native D2 
dimer interface. However, at 37 °C with more dynamics we may allow for more non-native 
pathways to be accessible, the protection pattern as observed by qHDX may change.  
The other mutant with observed altered protection compared to other mutants expressed at the 
same conditions, G93A at 25 °C (Figure 3.4C), is a highly conserved residue situated within L5 
and shows increased protection in L6 and β8, and less protection in L4. As with V148G expressed 
at 37 °C, this could imply that increased populations of non-native dimer D2 may be observed for 
rApo G93A expressed at 25 °C. As well, G93A has been shown to be able to weaken the native D1 
dimer interface, despite being far from the dimer interface84. Additionally, like V148G, this 
perturbed structure is only present at one temperature, however in this case the altered protection 
is observed at the lower temperature, 25 °C, as opposed to the higher temperature, 37 °C (Figure 
71 
 
3.8). The mutant G93A, being situated in L5 close to β6, may be disrupting the packing of L6 in 
the native-like structure, resulting in the aggregate ensemble shifting towards a structure with a 
more highly protected L6. As for why this change in protection only occurs at the lower of the two 
expression temperatures, some population of G93A SOD1 could be trapped in a non-native local 
minimum in the energy landscape funnel model of folding and cannot escape at the lower of the 
two expression temperatures. At 37 °C, where more thermal energy is available to the system, the 
protein may be able to surpass this minimum and form, predominantly, its native structure. This 
could be a potential explanation as to why the mutant at 37 °C appears to have a more native-like 
D1 dimer interface than at 25 °C. However, specific explanations as to why differences in 




Figure 3.8: Comparison of fraction amide protection between expression conditions.                                       
(A) Bar plot comparison of the fraction amide protection of G93A across all three expression 
conditions. Each bar is the averaged protection of two biological replicates. Error bars represent 
propagated error and were calculated using Eq. 6 (see below). (B) Bar plot comparison of the 
fraction amide protection of V148G across both rApo expression conditions. Each bar is the 




The IBs were further analysed using FTIR and CR spectroscopies. These data were acquired 
and analysed by Dalia Naser, Anna Schaefer, and Bruna Siebeneichler, all members of our group 
with whom I worked in collaboration. These data are included within this document with 
permission to add complementary structural information on SOD1 IBs.  
FTIR and CR spectroscopies were employed to measure the IBs secondary structure and 
amyloid content, respectively. Consistent with the qHDX results, the spectra of the SOD1 mutant 
IBs coincide closely, demonstrating extensive structural similarities among the mutant IBs. The 
spectra and secondary structure analyses of IBs are akin to those of native rApo and holo SOD1 in 
solution (Figure 3.9A,B), in agreement with native-like features in qHDX. In contrast, there are 
larger differences between the average IB spectrum compared to heat denatured SOD1 and 
sonicated SOD1, which has characteristic features of amyloid106. Amyloid typically exhibits 
absorbance at low wavenumbers arising from short intermolecular hydrogen bonds (<1630 cm-1), 
which is prominent only for sonicated SOD1. Significant absorbance at high wavenumbers (>1680 
cm-1) for IBs, native SOD1, and aggregates of rApo SOD1 in rats overexpressing human G93A 
SOD1107 is characteristic of antiparallel β-sheet and turns. Conversely, parallel β-amyloid lacks 
absorbance in this region108–110, as is also apparent for sonicated SOD1. Curve fitting of secondary 













         Eq. 6  
Where:  
x = average scaled qHDX signal for a condition 
y = averaged scaled protonated signal for a condition  
z = ratio of the x/y 
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data indicate a lack of extensive amyloid structure, some disorder, and substantial presence of 
native-like conformations in the IBs. 
 
Figure 3.9: FTIR and CR Spectra of IBs exhibit Native and Amyloid Features. 
(A) ATR-FTIR spectra in the amide I region for average IB, pure native reduced apo (ra) and holo 
pWT, ra A4V sonicated, and heat unfolded at 55 ºC. Spectral regions for antiparallel β-sheet (β⇵), 
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β-turn, α-helix (α), unstructured (unst), β-sheet (β), and β-amyloid with strong intermolecular 
hydrogen bonds (β#) are indicated. (B) Integrated area of secondary structure bands from curve-
fitting analysis and the holo SOD1 x-ray structure111. (C) CR difference absorbance spectra for 
mutant IBs, uninduced cells, and pure holo, ra and sonicated amyloid SOD1. 
The binding of CR to amyloid causes a red-shift in the CR absorbance spectrum, with maximal 
difference at ~541 nm112. Sonicated SOD1 exhibits typical CR spectral features corresponding to 
amyloid106. The spectra of mutant IBs are muted in comparison (Figure 3.9C), and more closely 
resemble the CR binding of uninduced cells. Importantly, ALS is not an amyloid disease and 
aggregates of SOD1 in ALS do not have amyloid characteristics113. CR spectroscopy is therefore 
also consistent with limited amyloid structure in the SOD1 IBs.  
Taken together the results presented herein provide compelling evidence for substantial 
native-like structure in SOD1 IBs, based on: 1) correlation of increased IB formation with 
decreased fALS mutant ΔGd and consequently increased population of folded, aggregation prone 
monomers84 2) native-like pattern of qHDX protection in IBs; 3) similar secondary structure by 
FTIR in IBs and native SOD1. In addition, associations of native-like and partially folded SOD1 
conformations similar to ones previously reported25,98,102–104 will confer protection of residues in 
loops, which are unstructured in native reduced apo SOD125,99. In-cell NMR of SOD1 in E. coli 
exhibits only native signal for W32, a reporter of global folding, as well as disordered signals 
indicating multiple SOD1 conformations104,114. In addition, amyloid structures are not prominent 
in the IBs, based on CR and FTIR spectral features and the distribution of qHDX protection beyond 
potential steric zippers. Collectively, these findings provide strong support for a model of SOD1 
IB formation comprising an ensemble of pathways, including a range of prominent native-like as 
well as some amyloid-like conformations (Figure 3.10).  
76 
 
The ensemble model explains why SOD1 point mutations generally have very little effect on 
IB structure: no single mutation substantially alters all pathways and self-association interfaces.  
The outlier that proves the rule is V148G: due to its central location in multiple interfaces, this 
mutation significantly shifts the IB aggregation ensemble. Interestingly, decreasing SOD1 stability 
by mutation, or increasing temperature, tends to increase the proportion of protein in IBs, while 
increasing SOD1 stability through the addition of zinc decreases the proportion of SOD1 in IBs 




Figure 3.10: SOD1 IB Formation Involves Multiple Pathways that Include Native and Non-
Native Interactions. 
Loops are coloured as in Figure 3.3. D1, D2, D3 form in solution25,104. Gain of interactions in 
crystal structures include: GOI1, an “amyloid-like” filament of near-native dimers where L7 (red) 
packs against the β5-β6 edge strands of the next dimer including intermolecular hydrogen bonding 
(PDB entry 1OZU) 98,102; GOI2 is a corkscrew oligomer model (5IIW)100; GOI3-5 are peptide 
steric zippers (4NIP, 4NIO, 4NIN) that may form from D1-D3 and contribute to assembly of more 
or less native-like species resembling GOI1 or GOI2 97. 
Our findings for SOD1 IBs are of broad significance for understanding and, ultimately, 
controlling cellular protein aggregation. SOD1 IBs may resemble high quality, native-like IBs115, 
which are desirable for the production of native proteins and as functional protein particles76,77,116. 
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The structural characteristics of SOD1 IBs and effects of mutations may be valuable for advancing 
rational design of IBs, currently an inefficient endeavour with often unpredictable outcomes. In 
addition, comparisons between the fALS mutant SOD1 IBs and disease aggregates highlight key 
similarities and differences in the assemblies of different proteins. SOD1 IBs and aggregates in 
ALS models81,107 and patients113 exhibit similar characteristics. The common antiparallel-β 
structure of the SOD1 aggregates contrasts with the prominent parallel β-amyloid in mature 
inclusions of other unrelated proteins in amyloid diseases, such as immunoglobulins, prions and 
Aβ110,117, although some early stage aggregates of these proteins also contain significant 
antiparallel structure118,119. The cellular structures and impacts of aggregates can be affected by 
many factors, such as the stage of assembly or age of the aggregate, biophysical characteristics of 
the aggregating protein, interactions of the protein with a variety of cellular species, and the 
specific procedures used for aggregate isolation and characterization75,78,117,120,121. For example, 
different cellular aggregate structures determined at moderate resolution by mass spectrometry 
qHDX for prion proteins exhibit widely varying toxicity that varies with the method of aggregate 
preparation122,123. It is therefore crucial to be mindful of such factors when, for example, seeking 
to develop therapeutics to target protein aggregation. The qHDX method highlighted here has the 
advantage of minimal sample processing and associated changes to the protein structures formed 
in cells.    
3.5 qHDX applied to other proteins 
qHDX has been applied to Adnectin IBs by Anna Schaefer in our group. All data acquisition 
and analysis has been completed by her. Her data are included in this thesis with permission as an 
additional comparison to SOD1 IBs, as well as proof of this method successfully being applicable 
to another unrelated protein. 
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Adnectins, a family of engineered proteins derived from the human 10th fibronectin type 3 
domain, have β-sandwich immunoglobulin-like structure with three loops analogous to the 
complementarity determining regions 1-3 of antibody variable domains. This allows them to bind 
with high affinity and specificity to a wide variety of targets making them attractive for a wide 
variety of applications53,124,125.  Adnectins also serve as a powerful system for unravelling specific 
molecular determinants of IB formation owing to the existing knowledge of their aggregation 
behaviour and propensity24. Preliminary studies conducted for two Adnectin mutants reveal 
protection patterns resembling those of SOD1 (Figure 3.11). Furthermore, the general pattern is 
maintained between mutants, despite their widely different solubilities. While a comprehensive 
study is ongoing, widespread protection throughout the sequence agrees with the previous proposal 
that Adnectin aggregates retain native-like structure24.   
 
Figure 3.11: Structure of Adnectin IBs from qHDX analysis. 
A) Average qHDX protection of two biological replicates of Adnectin V75R (model based on PDB 
1FNF made with software Swiss-Model126). Protection fractions from 0.5 to 1.0 are coloured as 
light to dark blue, respectively. Grey indicates no data. B) Average qHDX protection of two 
biological replicates of Adnectin L78I (model based on PDB 1FNF made with software Swiss-
Model126). The two mutants have very similar protection, implying similar IB structure, as 




In conclusion, this study presents a coherent basis for understanding many previously 
unconnected observations of SOD1 self-association as an ensemble process, which may be similar 
to the aggregation of many other proteins. qHDX observed by NMR is demonstrated as an 
accessible and valuable tool that may be applied to determining the impacts of biological and 
processing variables on IB structures at high resolution and so advance fundamental knowledge of 
the molecular basis of protein aggregation in cells as well as the rational modification of such 










IBs are a type of aggregate that can be found in recombinant bacteria with many practical 
medical, biotechnological, and industrial applications. Presented is a method, qHDX, that has been 
optimized to measure the high-resolution structure of IBs. High-resolution structural data on these 
aggregates provides the opportunity to improve upon these practical uses. Through measuring and 
controlling the structure of IBs, one could potentially engineer IBs with specific biophysical 
properties that can aid in these applications by developing more advanced recombinant expression 
systems. 
qHDX NMR has been optimized for IB study on the model protein, SOD1, and has been 
shown to provide consistent, high-resolution information on individual amino acid amide 
protection. Interestingly, qHDX NMR with supporting FTIR and CR data display extensive 
protection throughout the aggregate, indicative of native-like structures within the IB. This 
conclusion holds true across the three measured expression conditions of SOD1: 4 hours at 37 °C 
(rApo), 4 hours at 37 °C (with Zn), and overnight at 25 °C. Surprisingly, all conditions do not 
deviate in amide protection from each other, supporting the argument that SOD1 IB aggregation 
is through an ensemble of pathways independent of expression conditions or mutation.  
As demonstrated, qHDX can be readily applied to explore many different recombinant 
expression systems and proteins. Ultimately, high-resolution qHDX structural analysis of IBs 
promises to illuminate molecular determinants of IB formation and provide valuable information 
to tailor IB formation in a host of practical applications. This powerful method has the potential to 
lead to important advancements in the field of protein engineering, as it is an effective and efficient 
way to determine the high-resolution structure of protein aggregates formed in vivo. 
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4.2 Future Work 
 There are plenty of interesting avenues to follow in the future using qHDX on both SOD1 
as well as other systems. One potential path to pursue would be the qHDX analysis of loop 6 
mutants of SOD1. Potential mutants can include E100G and L106V, both being mutants shown to 
aggregate into IBs through previous analyses by members of the Meiering group, as well as being 
associated with the development of ALS. Loop 6 mutants would be of interest due to it being a 
hotspot of differences in our data sets. As mentioned in Chapter 3, loop 6 differs significantly from 
the average protection of V148G expressed for 4 hours at 37 °C, as well as G93A expressed 
overnight at 25 °C, having increased fraction amide protection in both cases.  
 Performing this analysis on a complete set of mutants grown and expressed in the presence 
of Zn would be of interest as well. While the three datasets that have been analysed do not show 
significant differences between the non-metalated aggregate species, it would be beneficial to 
include more mutants for analysis to state with confidence that the same species is aggregating in 
both the reduced apo and Zn-bound species. Ideally, the entire 9-set of mutants analysed for SOD1 
IBs expressed for 4 hours at 37 °C would be sufficient to confirm if this is indeed the case.  
 Finally, it would be of interest to see the expansion of the qHDX method, and its application 
on entirely new proteins and their aggregates using this method. As highlighted in Chapter 3, our 
group has begun analysing the structure of Adnectins that form IBs, but it would be of interest to 
look at entirely new systems. Examples of such systems could include the disordered C-terminal 
domain of TDB43, as well as myoglobin. qHDX observed through NMR is a powerful tool that 
can serve as a key piece in understanding the puzzle that is protein aggregation. This method could 
help elucidate protein local stability, global stability, and secondary structures within in-vivo 
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Figure A2.1: Amide exchange decay fits in CCPTNMR software. 
CCPNMR produces an output of the intensities of each assigned cross peak in the series of 1H-15N 
HSQC spectra fit as a function of time. Here, a series of 150 1H-15N HSQC spectra were obtained, 
assignments were transferred automatically throughout the series after manual transfer to one 
spectrum. The output produces a fit in the form of (I = Io*e
(-k*x) + C), with I being the intensity at 
time x, Io being the initial intensity, -k being the kint, and C being the signal of the cross peak at 





Figure A2.2: Effects of pH on 1H-15N HSQC cross peak intensity and chemical shift. 
Replicate samples with different pH values. Areas where signal intensities differ greatly are 
circled, and areas where there are larger differences in chemical shifts are marked with arrows. 
The random coil region (~7.8 - 8.2 ppm) also displays larger variability in peak intensity and 





Figure A2.3: 1H 1D NMR spectra overlaid to highlight differences in water content across 
samples. 
Here we have three spectra: Blue) a spectrum where the H2O signal (3.815 ppm) is supressed, 
allowing for the residual DMSO signal (2.512 ppm) to be observed; Green) a spectrum where the 
DMSO signal is supressed and the H2O signal is deemed acceptable; and Red) a spectrum where 





Figure A2.4: Overlay of 1H-15N spectra at different acquisition temperatures. 
A series of temperature controlled 1H-15N HSQC spectra show that cross peaks move mostly 
uniformly in the unfolded protein, allowing for resonance assignments of a spectrum measured at 






Figure A2.5: Effects of varying IB storage. 
A) Replicate samples, one analyzed immediately after lyophilization compared with one analyzed 
after storing the sample at -80 °C for three months. Some changes are observed, notably for 
residues with lower protection. B) Replicate samples analyzed immediately after lyophilization or 
are storage at 25 °C for two weeks. Extensive differences are observed, likely due to signal 
scrambling due to H-D exchange in the lyophilized sample. C) Replicate samples, both analyzed 
immediately after lyophilization. The high correlation shows that the most consistent results are 





Figure A2.6: 1H-15N spectrum of A4V SOD1 unfolded in 95% DMSO / 5% H2O at pH 5.5 with 
backbone residue assignments. 
Sequence specific resonance assignments made at 25 °C as described in 2.5.3. Assignments were 
obtained for 126 of 148 non-Pro residues. Unassigned cross peaks for sidechains are labelled as 






Figure A3.1: SDS-PAGE of mutant SOD1 IB formation and disulphide status. 
(A) Samples of cell culture taken at 2, 4, and 6 hours post induction at 37 °C (top) and 25 °C 
(bottom) were lysed and centrifuged, then soluble (S) and insoluble (P) fractions were analyzed 
by 15% SDS-PAGE. Gel densitometry was performed on the SOD1 band in each lane using 
TotalLab 100 software package (Non-linear Dynamics) with rolling ball background subtraction. 
%SOD1 in IB = P/S+P x 100%. (B) Samples taken at 4 hours post induction at 37 °C  were treated 
with iodoacetamide to label free thiol groups in Cys residues, then analyzed by  15% non-reducing 
SDS-PAGE to determine the thiol status of the cysteine residues in the IBs. SOD1 with Cys 
reduced (SH) or oxidized (S-S) migrate differently in SDS-PAGE. The IB pellets contain primarily 





Figure A3.2: The % of SOD1 that forms insoluble IBs increases at higher growth 
temperature. 
% SOD1 in IB is calculated as in Figure A3.1 for samples taken at 4 and 6 hours post induction at 25 °C,   
30 °C (both typically in triplicate) and 37 °C (single measurements).  Data are shown as box-and-whisker 
plots, with horizontal lines at the median, box enclosing 50% of the data.  Whiskers represent the minimum 
of the lower quartile and the maximum of the upper quartile, respectively. Outliers are greater than 1.5 









Figure A3.3: Normalized Delta Predictor Scores. 
Delta prediction data are presented for all mutants, besides V148G which is included in the main 









Figure A3.4: Protection ratios - rApo expressed at 37° C for 4 hours. 
Ratio of the fraction amide protected for each mutant to the average fraction amide protected for 
all mutants expressed with these conditions (A4V, G37R, G41D, G41S, G85R, G93A, G93D, 
V148I). V148G is excluded from this average due to it having increased protection in loop L6, and 
decreased protection in loop L4 and β8. The red line represents a value of 1.0, any data points 
above this line have a higher observed protection relative to the average, and any points below this 





Figure A3.5: Protection ratios - rApo expressed at 25 °C overnight. 
Ratio of the fraction amide protected for each mutant to the average fraction amide protected for 
all mutants expressed with these conditions (A4V, G85R, V148G). G93A is excluded from this 
average due to it having increased protection in loop L6 and β8, and decreased protection in loop 
L4. The red line represents a value of 1.0, any data points above this line have a higher observed 





Figure A3.6: Protection ratios - Zn expressed at 37 °C for 4 hours. 
Ratio of the fraction amide protected for each mutant to the average fraction amide protected for 
all mutants expressed with these conditions (A4V, G85R, G93A). The red line represents a value 
of 1.0, any data points above this line have a higher observed protection relative to the average, 





Figure A3.7: Biphasic exchange of IB amide protons in D2O. 
Aliquots of IBs from the same culture expressing G85R SOD1 grown at 37 °C and harvested at 4 hours 
post-induction were incubated in D2O for 0 (protonated), 2, 60, and 240 at room temperature, and for 1 
week and 2 weeks at 4 °C (converted to 1750 and 3480 minutes, respectively, at 20 °C using SPHERE46,127). 
To guide the eye, solid lines show fits of the biphasic time course of exchange in D2O to a double 





Figure A3.8: 1H-15N HSQC spectra for aliquots of G85R SOD1 IBs at different times of 
exchange in D2O. 
A: Fully protonated, not incubated in D2O (0 minutes); B: Exchanged for 1 hour (60 minutes) in D2O at 
room temperature; C: Exchanged for 4 hours (240 minutes) in D2O at room temperature; D:  Exchanged 





Figure A3.9: Comparison of amide protection between different expression conditions. 
(A) Fraction amide protection of A4V SOD1 at all three expression conditions. Each bar is the 
average of two biological replicates. No significant differences in protection were detected 
throughout each condition. Error bars represent propagated error and were calculated using Eq. 
6. (B) Fraction amide protection of G85R SOD1 at all three expression conditions. Each bar is 
the average of two biological replicates. No significant differences in protection were detected 
throughout each condition. Error bars represent propagated error and were calculated using Eq. 
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138 GLY N 107.567 
139 ASN H 8.121 
139 ASN N 117.008 
140 ALA H 8.24 
140 ALA N 121.802 
141 GLY H 8.223 
141 GLY N 104.51 
142 SER H 7.868 
142 SER N 112.942 
143 ARG H 8.196 
143 ARG N 120.303 
144 LEU H 7.897 
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144 LEU N 118.293 
145 ALA H 8.011 
145 ALA N 121.22 
146 CYS H 7.927 
146 CYS N 114.554 
147 GLY H 8.217 
147 GLY N 107.808 
148 VAL H 7.789 
148 VAL N 114.773 
149 ILE H 7.905 
149 ILE N 119.43 
150 GLY H 8.156 
150 GLY N 109.287 
151 ILE H 7.747 
151 ILE N 115.978 
152 ALA H 8.135 
152 ALA N 124.191 
153 GLN H 8.046 
153 GLN N 116.48 
Table A3.1: 1H-15N backbone assignments of A4V SOD1 in 95% DMSO / 5% H2O at pH 
5.5. 
All A4V SOD1 resonance assignments were determined by Dalia Naser in the Meiering group. 
